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The common theme in the various works presented in this thesis is the use of gold nanoparticles 
(AuNPs) for the detection of biomarkers. This can be attributed to both the optical properties of 
AuNPs that make them ideal as tags and readout platforms, as well as a pressing need for the 
detection of biomarkers in the clinical setting.  
The main technique involves the use of DNA-AuNP conjugates that detect molecular targets, 
with the resulting nanoassembly being the definitive readout of a successive detection event. The 
works presented in this thesis show that, through the careful design of the AuNP probes and the 
assembly process, AuNPs could be combined with various platforms (gel, TEM, DLS, 
fluorescence spectrometry) to achieve distinct and unique readouts for gene, RNA and protein 
biomarkers sensing. The control in the fabrication and assembly processes also makes the 
systems distinct from typical AuNP detection platforms solely centered on the aggregation 
process, which are largely uncontrolled and lead to variable readouts that generally work against 
their use in diagnostics. Such control also means that only very specific occurrences can bring 
forth the desired readout, such as two probes binding onto a target and giving rise to dimers, or 
transcription factors interacting with dimers through its binding site localized within the dimers.  
Other than AuNP probes and nanoassemblies being the common link for the different projects, 
another thing that unifies the various works is their progression through the cellular information 
transfer machinery (central dogma). DNA hold genetic information and are detected through the 
formation of dimeric AuNPs. Different-sized AuNP probes specific for mutant variants of the 
glucose-6-phosphate dehydrogenase gene were fabricated, and a multiplex diagnostic system 
was developed. On the agarose gel platform, at least 4 variants were distinguished using AuNPs 
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of 8 different sizes. Following that, miRNA - regulators of the transcription machinery, was 
detected with an AuNP-DLS tandem. The formation and growth of the AuNP assembly in the 
presence of let7 target was presented as a distinct size change signal on the DLS, which provided 
rapid and sensitive detection with good selectivity between closely related members of the let7 
family. Furthering the AuNP assembly detection of biomarkers, dimers were also used as probes 
for the detection of protein targets. Specifically, dimers bridged by DNA carrying the recognition 
sequence of estrogen receptor (ER) were fabricated. The subsequent interaction between ER and 
the dimers was evidenced by the presentation of a complex peak signal on the DLS, which in 
turn highlighted the presence of the protein target. 
Last but not least, unique DNA architecture was explored in the development of a G-quadruplex-
induced nanoassembly process. Through the use of poly-G DNA, quadruplex formation, and 
modulation by molecular hairpins, AuNP assemblies was achieved and then optimized. This was 
followed by the proof of concept detection of the let7a miRNA in a dual-tier process brought 
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CHAPTER 1: Introduction   
1.1 Motivation 
The characterization of diseases is centered upon two key elements - Diagnosis, which is to 
determine the presence of the disease with certainty, as far as existing knowledge of the 
condition goes, and Prognosis, which refers to the expected recovery or survival rates. These 
will then affect decisions taken for medical treatments best possible for the patients. To this 
end, biomarkers have been a key component to disease diagnosis and prognosis. Often, it is 
not easy to pinpoint a particular condition. For example, under what given condition is an 
individual declared a cancer patient, and what treatment is most beneficial to the patient? 
Thus, biomarkers have proven to be useful as surrogates for the disease condition since the 
presence or regulation of biomarkers was found to be significantly related to the disease. An 
example is the estrogen receptor (ER), which is a biomarker for breast cancer. Typically ER-
positive patients respond more positively to specific drug treatment and show better survival 
rates. This information has also helped medical personnel administer more appropriate 
treatment, or seek alternative medication for ER-negative cases. ER is now a commonly 
screened biomarker in cancer treatment facilities.  
While protein biomarkers more directly lead to physical manifestations of abnormalities, 
there exist many other biomarkers across the genome, transcriptome and proteome. And more 
importantly, there is an intrinsic relation between the different -omic levels - genetic 
mutations lead to erroneous transcripts and their regulation, which cause proteins to 
malfunction. Thus, it is inadequate to look at a single biomarker when trying to pinpoint a 
condition, nor is it enough to query at a single -omic level. If a condition can be considered 
across the genome, transcriptome and proteome, and with a study of a panel of biomarkers 
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across these levels, much more valuable information can be discovered, possibly leading to 
better recovery and survival rates in patients. 
On the other hand, even if a biomarker is valuable, it must still be successfully detected in the 
first place. There have been many molecular techniques that had been developed for the 
detection and study of nucleic acids and proteins, but areas of unmet need still persist. For 
example, PCR and microarray systems need specially designed probes for targets that are of 
short-length (such as miRNA), which in turn leads to nonspecific bindings and false positives 
in readout. Long processing times also hamper techniques such as northern blots and 
sequencing, while the use of the latter is still constrained in its high cost.   
This is where nanotechnology, and specifically nanoparticles (NPs) have proven to be 
especially useful. Given the unique physical properties of NPs, different detection designs 
have been proposed to bring about biorecognition and visualization. There have been many 
successful examples and they will be discussed in the various chapters. However, many of 
these NP-based systems are still largely focused on improving the detection limits (and they 
have been largely successful), but prove to be complex to operate or fall short in other 
properties expected of good sensors. Essentially, systems that can provide direct readouts will 
allow more ready usage and cause less pressure for the end user to have extensive technical 
knowledge or machinery in order to utilize the as-developed platform. Thus, gold 
nanoparticles (AuNPs), exhibiting ideal optical properties (surface plasmon and spectral 
shifts) and amenable for functionalization with recognition moieties such as DNA, are ideal 
as readout platforms to transduce biorecognition events and to show the presence of 
biomarkers. AuNPs are also the main agents from which the various detection systems 
discussed in this thesis are built upon.  
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It is with all these motivations that the detection of various biomarkers across the different -
omic levels is the focus of the thesis, primarily through detection with AuNP nanoassemblies 
that result when a target biomarker is present. In addition to a successful detection process, 
the techniques presented are also rapid and simple to use, while showing the sensitivity and 
selectivity that all good detection systems should exhibit.  
Essentially, based on the central theme of biomarker detection with AuNP nanostructural 
assemblies, this thesis is made up of a number of unique works: 1. To develop a 
nanostructure system for the detection of different mutations of the glucose-6-phosphate 
dehydrogenase (G6PD) gene. This multiplex assay allowed different single nucleotide 
variants of the G6PD gene to be screened, providing information on the particular genetic 
status of an individual; 2. To extend the DNA hybridization works onto the dynamic light 
scattering (DLS) platform, which is ideal as a complement for AuNPs. The presence of 
microRNA (miRNA) targets resulted in the formation and growth of unique nanoassemblies 
(dimers, trimers and higher order -mers), which elicited distinct size change signals on the 
DLS; 3. To combine the formation of dimeric nanostructure with DLS for the detection of the 
ER protein. The presence of the ER-binding site on the dimers allowed the binding of the ER, 
and which formed the basis for the detection of ER. The interaction between dimers and ER 
was translated into a unique complex peak signature observed on the DLS; 4. Understanding 
the poly-G (PG)-linked AuNPs and how the PG-induced quadruplex formation could lead to 
unique nanoassemblies, and modulating the quadruplex- and nanoassembly-forming 
processes with molecular hairpins. Subsequently, this led to the development of a dual tier 
nucleic acid (miRNA) sensing system with the combination of molecular beacons (MB) and 
PGs. While the target here is single miRNA, the concept of a dual detection system could 
readily be applied for the detection of two (and more) targets. 
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The following chapter begins a review of the literature on some of the key aspects that were 
featured in this thesis, namely biomarkers at different levels of the cellular information 
transfer network, and also AuNPs which is central to all the detection strategies and systems 
developed. Chapters 3 and 4 present results on the AuNP assemblies first used for gene 
detection, then miRNA biomarker sensing. Following which, AuNP assembly, instead of 
being an endpoint readout, was evolved for use as probes for the next level of detection, with 
AuNP dimers used to detect protein biomarkers (Chapter 5). These works show that, through 
careful design of the detection system, the highly versatile AuNPs could progressively be 
used for wide-ranging sensing purposes that span across the cellular information transfer 
machinery. And this is possible due in large to the base pair recognition ability of DNA, 
which is central for the formation of nanoassemblies. A unique property of DNA was next 
discussed in Chapter 6 in which the G-quadruplex was studied using AuNPs, which in turn 
was developed into a dual-readout diagnostic system for miRNA. Potentially, such a system 
could be used to screen for different nucleic acid and drug targets. And the multiple readout 
could be further explored for the detection of a panel of biomarkers, the eventuality of which 
would unify the different works presented. Essentially, Chapters 3 to 5 can be viewed as a 
sequential study of biomarker detection from the genomic, to transcriptomic and finally 
proteomic levels. Chapter 6 shows how the AuNP assembly system could be further evolve to 
present a multi-tiered readout, which potentially can lead to a multifactorial detection 
scheme. Also, the control over the different systems was made possible via careful design and 
consideration of the assembly processes, which addressed an aspect that is important in 
detection works. Last but not least, all the readouts were direct and unambiguous, which 
fulfils an area of need for all good biosensing systems. The last chapter touches on the areas 
where the works could be of further improvement. More importantly, the future outlook of 
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CHAPTER 2: Literature Review 
2.1 Biomarker and detection 
The use of biomarkers in medicine has significant implications in the prediction and 
prevention of diseases such as cancer and diabetes, as well as important roles in the diagnosis 
and prognosis during medical treatment. Biomarkers range across all levels of the cellular 
machinery - DNA and their mutations at the genomic level, aberrant non-functional proteins 
at the functional, proteomic level, and also in variations of miRNA levels which are key 
regulators of the cellular machinery. In this section, we will look at the criteria that define a 
good biomarker, and discuss the different types of biomarkers typically studied and how they 
can characterize a disease.  
 2.1.1  Qualification as a biomarker 
  2.1.1.1 DNA (Single Nucleotide Polymorphisms) 
Most nucleic acid biomarkers are based on genetic variations that occur within the 
population. Many diseases are associated with DNA abnormalities like mutations of 
individual base residues, mitochondria DNA mutations, chromosomal aberrations such as 
translocations or deletions, and also epigenetic changes with differential methylation status 
[1]
. In particular, one of the most dominant forms of genetic variations is single nucleotide 
polymorphisms (SNPs), which refer to single base difference in similar genetic loci between 
individuals, at which the rarer base occurs in > 1% of the population 
[2]
. The discovery and 
validation of SNP has steadily progressed, and the number of SNPs recorded in the dsSNP 
database has increased from 1.5 million in 2001 to over 1.8 million till date 
[3, 4]
. More 
importantly, the association of different SNPs across the genome has allowed the 
construction of genetic maps that identify a panel of particular mutations which, if exist, may 
suggest a greater likelihood of certain diseases. For example, Goate and co-workers studied 
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the CALHM1, GAB2 and SORL1 genes and how variants of these genes could affect 
cerebospinal fluid (CSF) amyloid-β (Aβ) level and the phosphorylation status of the tau 
protein, conditions commonly studied in Alzheimer's cases 
[5]
. The group found association 
between the minor allele of rs2986017 in CALHM1 and CSF Aβ, and the gene variants 
provided insight to the effect of Aβ in modulating the risk of Alzheimer's disease. Other 
conditions in which SNPs are contributing factors include the prognostic biomarker PAI 1-
4G/5G in breast cancer, with homozygote patients being afflicted with more aggressive 
cancers 
[6]
, rheumatoid arthritis where a large panel of SNPs contribute to specific point or 
loci mutations related to the disease 
[7]
, and also the lumbar disc disease where a particular 
SNP mutation encoding for the cartilage intermediate layer protein is responsible for 
increased susceptibility to the disease 
[8]
. In addition, SNPs could affect individual response 
to drugs as seen from a study of 138 potential SNP biomarkers from the VEGF pathways in 
which a number of SNPs were found to be related to poor response to the anti-VEGF 
treatment process by bevacizumab 
[9]
. A single SNP might also be responsible for multiple 
disease conditions such as polymorphisms in the α3/ α4/ β4 nicotinic receptor subunit being 
linked to nicotine addiction, peripheral arterial disease, and lung cancer 
[10]
.  
In this thesis, one particular condition that will be explored in detail is the mutations in G6PD 
gene and how we have developed a technique for the multiplex detection of the different SNP 
variants in the G6PD gene. 
  2.1.1.2 MicroRNA 
It is known that mRNA is processed before it is used as template for protein synthesis, and 
this is done through the process of RNA interference. Double stranded RNA (dsRNA) known 
as small interfering RNA (siRNA) was found to bind to their complementary mRNA 
counterpart, leading to the selective silencing or knockdown of specific proteins. Firstly, as 
shown in Scheme 2.1, microRNA (miRNA) in its final form is created from the actions of the 
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Dicer and Drosha nucleases. And this is subsequently regulated by the RNA-induced 
silencing complex (RISC), which is a miRNA- and Argonaute protein-containing 
ribonucleoprotein 
[11]
. The RISC complex is guided to its target by the miRNA within the 
complex which is complementary to the mRNA. This leads to the subsequent degradation of 
the mRNA target. Through their effect on mRNA, miRNAs exert a regulatory effect on the 
genetic level as gene transcript amounts are tightly controlled.  
 
Scheme 2.1. Formation of mature miRNA from pri- and pre-miRNA via the actions of 




MiRNA expression fingerprint was found to correlate well with biological and clinical 
characteristics of cancer, such as tissue type and also response to therapy 
[13]
. From genome-
wide studies, abnormal expression of miRNAs was found in both solid and haematopoietic 
tumours. For example, abnormally expressed miRNAs were found to target transcripts of 
essential protein-coding genes implicated in cancer, with miR-21 being most highly 
implicated due to its over-expression in 6 cancer types and regulation in key tumour 
suppressors such as PTEN and TP53 
[14, 15]
. MiR-21 was also proposed as a candidate for the 
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diagnosis and prognosis of colorectal cancer and glioblastoma 
[16, 17]
. Other miRNA 
biomarkers that have been discovered and validated include the let7 family in various cancer 
types 
[18, 19]
, and also MiR-221 and MiR-222 in papillary thyroid carcinoma 
[20]
. Finally, MiR-
17-92 was found to have both tumour-inducing and suppressing functions 
[21, 22]
.  
Thus, we can see that miRNA is a valuable biomarker increasingly being the subject in 
detection systems. A significant portion of the works presented in this thesis is associated 
with miRNA detection, with the successful detection of this biomarker having many 
implications in the study and characterization of many diseases. 
  2.1.1.3 Proteins  
While SNPs and mRNA transcripts might affect the condition of a disease in individuals, the 
actual manifestation of the effect is typically due to the presence/absence of non-
functioning/functional proteins, which have a impact on the physiology. Thus, there is 
impetus to discover, study and detect protein biomarkers.  
For example, the human chrionic gonadotropin and activated leukocyte cell adhesion 
molecule are biomarkers for trophoblastic, breast, and epithelial tumours, as their blood 
plasma levels showed a distinct increase from ng/mL to µg/mL levels in the presence of the 
disease(s) 
[23, 24]
. Another protein biomarker that has received much attention is the 
carcinoembryonic antigen (CEA) which is associated with colorectal, ovarian, pancreatic and 
liver cancers. The CEA level was found to be elevated in all these cancer subtypes. Herein, 
we could see that biomarkers such as CEA are relevant in the diagnosis for multiple diseases 
[24, 25]
. While it may be questionable to probe for a biomarker that is not specific to a single 
disease, such biomarker is still useful since a given disease could be characterized by a panel 
of biomarkers of which the CEA could be one of them. This would give more confidence in 
pinpointing the disease, characterizing and treating it. For example, for the 'suspicious' 
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thyroid nodule condition, the benign cases can only be distinguished from its malignant 
counterparts to a limited extent. Often, up to only 20% of suspicious thyroid nodules removed 
are malignant, which suggested a waste of resource and money, as well as causing patient 
stress from surgeries. When new biomarkers were taken into account and a panel of 4 
biomarkers was used in the screening process, the accuracy of the diagnosis was found to be 
enhanced, which allowed both patient and medical personnel to make better-informed 
decisions 
[26]
. In an even more comprehensive study focused on Alzheimer's disease, a panel 
of 10 upregulated and 7 downregulated biomarkers were used to distinguish people with 
Alzheimer's from healthy subjects with good specificity and sensitivity 
[27]
. 
On the other hand, in one of most well-studied protein biomarkers - prostate serum antigen 
(PSA), we can also see why biomarkers should be used with caution. PSA has been widely 
studied as a biomarker to characterize prostate cancer. The free or complexed (with α-a-
antichymotrypsin) PSA, or the total PSA level of more than 10ng/ml was gauged as probable 
risk of the prostate cancer 
[28]
. However, not all prostate tumours are aggressive, with over 
30% of the malignant cases that are removed posing no health risk to the afflicted patients. 
However, as a result of surgery, patients may suffer the aftereffects such as incontinence and 
impotency, which seriously affect their quality of life. This shows that as useful as 
biomarkers are, they must be utilized and analyzed appropriately. For example, in Huo Qun's 
work of a nanoparticle-based prostate cancer scoring system, the degree of aggressiveness of 
the prostate cancer condition was quantified to allow better medical decisions to be made 
[29]
.   
 2.1.2 Breast cancer as a biomarker case study 
The multifactorial nature of a disease and the need for panel of biomarkers and multi-omic 
characterization is best represented by breast cancer, which is the second leading cause of 
cancer deaths in the United States. A 2012 report had estimated that, in that same year, over 
200 000 new cases of invasive breast cancer cases would be diagnosed in women in the US, 
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with a corresponding 40 000 deaths 
[30]
. And as stated in a recent 2013 report, there were 1.4 
million new cases of breast cancer worldwide and about 460 000 deaths 
[31]
. Given its 
seriousness, there is much impetus in breast cancer research and detection.  
In addition to genetic causes such as PAI 1-4G/5G already described, mutations in either the 
BRCA1 or BRCA2 genes accounted for 90 to 95% of familial breast cancer cases, which 
makes up for one quarter of breast cancer cases amongst women aged 30 years and below 
[32]
. 
The genetic basis of the disease has also led to the development of screening methods - 
Oncotype DX and MammaPrint. The former is a 21-gene scoring system that predicts risks of 
recurrence amongst patients with node-negative, ER-positive breast cancer. The latter utilizes 
a panel of 70 genes to predict metastatic risks in patients with node-negative early breast 
cancer, and allow adjuvant therapy to be administered earlier. Both methods have been 
commercialized and subjected to large scale phase-III trials 
[33]
. The breast cancer condition 
can also be described at the transcriptomic level with the let7 miRNA. It was reported that the 
let7 level in the chemo-resistant breast tumour initiating cells (BT-IC) was significantly lower 
than fully differentiated cancer cells 
[34]
. BT-IC are both the source of tumours and tumour 
progression, and one of the important factors in breast cancer treatment. By profiling the let7 
miRNA level in breast cancer cells (and in particular BT-IC), it may be possible to better 
characterize the disease and make a prognosis in better confidence 
[35]
. In addition, the let7a 
miRNA in particular has been found to be a tumour suppressor since its presence reduced the 
proliferation of breast cancer and alleviated metastatic risks through the down regulation of 
the C-C cytokine receptor type 7 
[36]
.   
The HER2/neu protein, being over-expressed in 10-34% of the invasive breast cancer cases, 
has been a prime biomarker target for the characterization of the breast cancer. There are 
FDA-approved commercial kits (Dako Herceptest™ and Ventana Pathway™) that determine 
patient suitability for the anti-HER2/neu drug trastuzumab 
[32, 37, 38]
. ER is another protein 
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target commonly studied. ER has much prognostic value as ER-positive subjects generally 
have better survival rates than ER-negative ones, which requires further endocrine therapy 
[39, 
40]
. However, in the case of epidermal growth factor receptor, despite showing early promise 
as a biomarker candidate for breast cancer, its efficacy was not fully established, and as such 
it is not routinely screened 
[32, 41]
. 
Herein, given the many biomarkers that are available for the characterization of breast cancer, 
the choice of biomarkers and the organization in their detection has a direct impact in the 
treatment outcome. This also stresses a need to have as comprehensive detection system as 
possible, which possibly spans across the different -omic levels. In particular, let7 and ER are 
two biomarkers that are the target of detection works presented in this thesis.   
2.2  Gold nanoparticles 
The advent of nanotechnology has led to improvements in molecular techniques in areas such 
as sensitivity, selectivity and immediacy of readouts. Nanoparticles offer unique properties, 
such as surface plasmon resonance, and they are amenable to bio-functionalizations, making 
them ideal as labelling tags or readout platforms 
[42-45]
. The aim of this section is to provide a 
comprehensive review of the gold nanoparticles (AuNPs), with a particular focus on their use 
in diagnostics. The understanding of AuNPs ranges from the controlled synthesis of AuNPs 
of different size, shapes and structures, to their functionalizations with different ligands. The 
ligands can enhance the AuNP stabilities in different environments, as well as impart 
biorecognition abilities. The use of AuNPs in biosensing is also the centerpiece of the 
different works that are presented in this thesis.   
 2.2.1 Synthesis of gold nanoparticles 
The synthesis of colloidal AuNPs of reproducible size in a safe and controlled manner is 
important on many levels, one of which is that the homogeneity in shape, size and structure 
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allow the products to have uniform physical properties, and this has direct impact on their 
applications in diagnostics. One of the earliest pieces of work regarding simple and direct 
ways for AuNP synthesis using the precursor gold salt, citrate and water was first reported by 
Turkevich 
[46]
. The nucleation-growth mechanism and the associated controlling factors, such 
as reductant concentrations, reaction time and temperature, were also reported. Frens also 
enhanced the understanding of the traditional nanocrystal growth via the nucleation followed 
by diffusion-controlled net growth route 
[47]
. In particular, the variation of citrate 
concentration allowed the direct control of the product size, with the increasing reducing 
strength of citrate being able to bring about smaller AuNP products and also act as a capping 
agent to stabilize the as-formed AuNPs. All these lent a good degree of control to the 
synthesis process, and also the size tunability of the products. However, the citrate-based 
technique was more amenable to obtain smaller-sized products (< 50nm). To get AuNP larger 
than 50nm, seed-mediated methods were typically employed 
[48, 49]
. The different reported 
techniques on the synthesis of colloidal gold are clearly summarized in Fig. 2.1 below: 
 





Peng and co-workers provided a different perspective to citrate-mediated AuNP growth 
process, with an in-depth look at the accepted norm of citrate as a reducing and capping agent 
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controlling AuNP growth 
[51]
. It was found that at high levels of Na3Ct/ HAuCl4, the AuNP 
size showed an inverse relation to the amount of citrate used. They reported that besides 
acting as a reducing and capping agent, citrate is a pH mediator, and controlling its addition 
into the reaction mixture can have a direct effect on the synthesis outcome. As seen from Fig. 
2.2, fixing the Na3Ct:HAuCl4 ratio at approximately 3 produced the smallest nanoparticle 
size.  
  




When the Na3Ct:HAuCl4 ratio decreased from 3 and below, the product sizes were 
progressively larger, as the conditions promoted the growth of nanocrystals in the traditional 
route of nucleation, followed by diffusion-controlled net growth 
[52]
. When the ratio increased 
above 3, there was a corresponding increase in product size, though the increase was more 
gradual. This could be attributed to the high citrate concentration which caused the reaction 
pH to be lower than the pH 6.5 switch point. As a result, there were changes to the structure 
and reactivity of the Au(III) complexes. Instead of nucleation-growth, the reaction pathway 
took the nucleation-aggregation-smoothing route, which resulted in larger-sized AuNPs. This 
report has significant implications in the works presented in this thesis, for different-sized 




In Fig. 2.2, it could be seen that with citrate as the sole reductant, it was not easy to achieve 
AuNP sizes less than 15nm. As such, protocols using a citrate-tannic acid combination are 
typically used for the synthesis of AuNPs of 15nm size and smaller. In the work by Handley, 
the combination of tannic acid as a co-reductant with citrate resulted in AuNPs of 10nm size 
and below with good monodispersity and stability 
[53]
. The citrate-tannic acid combination 
gave control over a large size range, with as small as 3nm AuNPs prepared. In addition, 
tannic acid acted as surfactant, which prevented aggregation of the AuNPs 
[54]
. Other 
reducing agents such as sodium borohydride, white phosphorous and ascorbic acid were 
reported in other preparation techniques, while polymeric stabilizers were also used to 
achieve AuNPs of 1-4nm size range 
[55, 56]
.  
In the methods presented, though reproducibility is an essential criterion, there are equally 
key areas that make the AuNPs more amenable for detection use. In particular, the 
monodispersity of the products means homogeneity in the physical properties of the products, 
which allows more consistent performance in subsequent applications. To this effect, 
reducing agents also play the role of capping agents in the synthesis process, and are 
important in the subsequent functionalization process. The capping agent can be regarded as a 
barrier that exerts a steric influence that prevented the uncontrolled growth of the AuNPs, as 
well as stabilized the products against uncontrolled aggregation 
[57]
. Examples of strong 
capping agents include thiol-based moieties such as mercapto acid 
[58]
, while compounds such 
as cetyltrimethylammonium bromide (CTAB) are weaker stabilizing agents 
[59]
. But the 
weak(er) stabilization by CTAB also play a functional role by allowing ligand exchange and 
imparting functionality and desirable properties to the AuNPs, such as biocompatibility 
[60, 61]
. 
This will be one of the areas of discussion in the next section.  
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 2.2.2 Properties of AuNPs 
The unique properties of AuNPs can be analyzed on many levels. There are intrinsic physical 
properties that exist due to the small size of the particles. The AuNP surface also interacts 
favourably with thiol moieties amongst other functionalities, which allows the attachment of 
biomolecules onto the AuNP surface. The resulting conjugates are then utilized for detection 
purposes. 
  2.2.2.1 Localized surface plasmon resonance (LSPR) 
LSPR is a phenomenon that results from the coherent and resonant oscillation of the 
conduction band electrons on the surface of metallic nanoparticles (NPs) when they are 
excited by incident electromagnetic (EM) waves. A number of factors affect this 
phenomenon, such as size and shape of the particle, inter-particle interactions, as well as the 
external environment 
[62]
. Distinct optical and electrical properties especially stand out due to 
the length-scale of NPs, which is much shorter than the EM waves. LSPR is especially 
commonly observed for AuNPs, giving rise to strong light absorption at characteristic 
wavelengths. For example, Link and El-Sayed found that the absorption wavelength maxima 
(λmax) of 9nm to 100nm AuNPs showed a progressive increase from 517nm to 575nm 
[63]
. 
Typically, the absorption spectra of AuNPs are dominated by an intense, sharp peak centered 
about 520nm, which reflect the surface plasmon band and result in the wine-red color of 
monodispersed AuNPs 
[64]
. There is also a blue shift in the absorption spectra of small AuNPs 
(<3nm), which is accompanied by a broadening of the absorption peak 
[65]
. Analogous to this 
size-dependent absorption character, a distinct red-shift in the absorption spectrum is usually 
observed for aggregated AuNPs 
[66]
. The aggregated AuNPs can be perceived to be a large-
sized particle system, thus showing a λmax at the longer wavelengths. This further reinforces 
the notion that the properties of AuNP are not attributed merely to individual NPs, but also 
inter-particle interactions and the environment. The understanding of the absorption property 
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of AuNPs has led to studies exploring the relationship between AuNP shape (gold nanoshells, 
and nanorods in addition to AuNPs) and size with their absorption characteristics. The 
absorption intensity at particular wavelengths also allows the concentration of the system to 
be estimated 
[67]
. While it would be simple to rely on the conservation of mass to estimate the 
amount of products derived from a given amount of reactants, the truth is more complicated 
due to the heterogeneity of the products. For purposes such as the bio-functionalizations of 
the AuNPs and control in conjugate fabrication (which will be explained in the later 
sections), it is imperative that an estimate be made as accurate as possible. According to Mie 
theory, the dielectric constant of capping ligands and environment are both contributors to the 
extinction coefficient of the AuNPs. There are also works which predicted the concentration 
of AuNPs with different capping ligands (citrate, decanethiol, oleylamine), and in different 
environments (water, THF, toluene) 
[68, 69]
. This is important since it is common to have 
AuNPs capped with stabilizing ligands as part of the synthesis process or post-synthesis 
modifications, and the medium of dispersion may be different depending on experimental 
needs.  
  2.2.2.2 Light Scattering 
While illumination of AuNPs results in absorption due to the nonradiative decay of the 
plasmons, the radiative pathway leads to the scattering phenomenon 
[70]
. The scattering 
exhibited by AuNPs are usually elastic, linear processes, which can be described by Rayleigh 
and Mie scattering 
[71]
. It was reported that the scattering property exhibited by AuNPs is a 
few orders of magnitude higher than commonly used dyes. In particular, spherical 40nm 
AuNPs showed 4 to 5 times larger scattering cross section than typical dyes like indocyanin 
green and malachite green, while 80nm AuNPs had comparable scattering to 300nm 
polysterene bead and 5 orders of magnitude higher than that of fluorescein 
[67, 72]
. The 
dominant scattering signature of AuNPs over other biomolecules provides a very good signal-
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to-noise ratio and makes AuNPs ideal for biological detection, especially in a complex matrix 
such as serum or tissue fluids. This is also a label-free method which further simplifies the 
detection process. Existing detection processes utilize the change in scattered light intensity 





scattering is dependent on the AuNP size, with 50nm AuNPs exhibiting green light scattering 
and 100nm AuNPs showing orange light 
[74]
. Although dynamic light scattering (DLS) is 
typically used to provide insight on the size and dispersity of the particles, it can also function 
as a detection platform 
[75]
. In addition, the scattered light intensity increases with the size of 
the particle system, with the Rayleigh theory describing that the scattered light intensity is 
proportional to the sixth power of the particle radius. This is ideally suited for aggregation-
based detections since the increased particle size yields a stronger signal 
[76]
. This also makes 
the light scattering detection systems far more sensitive than light absorption-based systems.  
Finally, unlike what has been discussed above, the surface enhanced Raman scattering 
(SERS) phenomenon associated with AuNPs is typically enhanced through the incorporation 
of Raman active dyes rather than attributed fully to AuNP metal core 
[77]
. 
  2.2.2.3 Gold nanoparticle-DNA conjugates formation/ functionalizations 
The understanding of the surface properties of AuNPs and the effect of different capping 
ligands has not only led to more stable AuNPs being synthesized, but also allowed their 
functionalizations with various compatible chemical moieties. This functionalization can 
occur in a number of ways, which include electrostatic attraction, chemisorption, covalent 
binding and affinity-based systems 
[78]
. The latter three are more commonly used strategies in 
functionalization processes since electrostatic interactions is highly sensitive to pH and 
changes in the environment and is less reliable. Covalent binding is most commonly 
described by the chemistry of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
hydrochloride (EDC) and N-hydroxysuccinimide (NHS), and is often used for attaching 
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proteins onto AuNP surfaces 
[79]
. Affinity based systems involve the use of the avidin-biotin 
chemistry, but it has drawbacks in that the large size of avidin may disrupt the stability of the 
AuNP colloids. A single avidin molecule binding to 4 biotins molecules can also complicate 
the control of the functionalization process, which may result in extensive cross-linking and 
even aggregation. Chemisorption has proven to be attractive in the AuNP functionalization 
process, with thiol moieties in particular showing extremely good affinity for noble metal 
surfaces 
[80]
. Biomolecules like DNA could be modified with the attachment of thiol 
functional groups at specific positions (usually at the ends), which allowed the subsequent 
conjugation of the DNA onto the AuNP surface, thus granting the particles bioaffinity 
[81]
.  
While the conjugation of DNA onto AuNPs by chemisorption is direct and useful, the greater 
use comes from control in the loading of DNA onto the AuNPs. The first presentation of 
discrete AuNP-DNA conjugates isolated via gel electrophoresis was done by Alivisatos and 
co workers. The technique did not just verify the success of DNA conjugation onto AuNP but 
also, through the bands that were resolved on the agarose gel electrophoresis, showed the 
type of conjugate that was formed (single, double, or multiple DNAs per AuNP) 
[82, 83]
. When 
DNA were conjugated onto the AuNP surface, the overall increase in the effective diameter 
of the conjugate system reduced the mobility of the AuNPs, resulting in their slower 
movement through agarose gel. Mass, not charge, is the dominant factor governing the 
conjugate mobilities. And with each additional DNA conjugated onto the AuNP surface, the 
effective diameter of the conjugate increased such that the mobility of the particle was further 
reduced 
[84]
. Typically, distinct bands were observed only for conjugates carrying the longer 
and more massive 100-base single strand DNA (ssDNA). With shorter ssDNA, such as 18b 
ssDNA, the distinct bands were not observed. Instead, the conjugates showed a smear on the 
agarose gel, which could be made more obvious with higher DNA to AuNP loading. Qin and 
Yung also reported on the use of enzymatic digestion of restriction sites to achieve AuNP 
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conjugates with a defined number of short ssDNA 
[85, 86]
. The AuNPs were first 
functionalized with long strand DNA which ensured distinct bands were observed on the 
agarose gel. Upon subsequent digestion of conjugates recovered from specific band level by 
restriction enzymes, conjugates bearing a defined number of short ssDNA were fabricated. 
While the agarose gel provided a ready and direct visualization of the AuNP conjugates, 
high-performance liquid chromatography (HPLC) was also found to be amenable for 
conjugate characterization and purification 
[87]
. On the other hand, the anisotropy of the 
conjugate formation process could also be controlled with the use of magnetic NPs for the 
directional functionalization of oligos onto the AuNP surface, which ensured the 
hybridization of other NPs in a specific orientation and the formation of unique 
nanostructures 
[88]
. The use of conjugates of defined structures in the construction of 
nanoassemblies is the focus of discussion in the next section. 
  2.2.2.4 Building blocks for nanostructure formation/ nanoassembly 
A distinction on what nanoassembly entails is first made here to aid the subsequent literature 
presentation. It is the orderly arrangement of single NP conjugate monomers into discrete 
dimeric and higher -meric structures. This is a stochastic process which is a bottom-up 
construction of defined nanostructures. In particular, a high degree of control can be applied 
to the construction of these structures such as through the use of hybridized DNA as bridging 
molecules, or interaction between functional groups. On the other hand, extensive 
crosslinking and charge interactions between AuNPs can also result in their aggregation. 
Such relatively 'large' structures usually do not show a defined size, and their formation is in 
a more uncontrolled manner. In the discussion in this section, the focus is on the use of 
AuNPs as building blocks in the bottom-up nanoassembly process. The aggregation of 
AuNPs is discussed in the later section on their use in colorimetric detection of various 
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biomolecules but aggregates are not considered as assemblies in the context of our review 
and work due to the uncontrollable nature of the aggregation process. 
The most immediate and direct assembly is the combination of two AuNP conjugates into a 
dimeric structure. The formation of dimers can be designed in a number of ways, and one of 
the most commonly used strategies is through the use of complementary DNA, which 
hybridize and bring their associated AuNPs together. The dimerization process had been 
well-described in the works of both Qin and Yung, and also Alivisatos. The former used the 
assembly of conjugates in a sandwich conformation, resulting in the formation of dimers 
[89, 
90]
, and possibly higher order nanostructures. The technique had been extended to diagnostics 
in which DNA mutations were detected. For the latter work, Alivisatos and co-workers had 
shown that with clever design of the complementary DNA sequences, the position of binding 
of conjugates onto target DNA could be readily controlled such that dimers and trimers of 
particular separation distances were fabricated 
[83, 91]
.  
The formation of nanoassemblies was further discussed in Mirkin and co-workers works 
which looked at how the melting properties of AuNPs were affected by factors such as DNA 
density on the AuNP, AuNP size, presence of linkers, dielectric of the local environment, and 
also salt concentration 
[92, 93]
. For example, it is considerably more difficult for two large(r) 
sized AuNPs to approach each other in a dimeric conformation due to electrostatic and steric 
effects, which is also affected by the linker length binding them together. In addition, in any 
hybridization experiments, the probe to target ratio is one of the important factors of 
consideration. For example, in the formation of dimeric nanostructures reported by Qin and 
Yung, too many probes resulted in single probes binding to a target but not dimer formation 
[89]
.  The same can happen when the target molecule is in too large an excess. This process is 
further complicated by the amount of recognition molecules present on the AuNP 
[94]
. Last 
but not least, the amount of salt in the environment exerts a screening effect which results in 
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the reduction in the electrostatic repulsion between AuNPs and facilitates the nanoassembly 
process. However, at too high salt concentration, AuNPs tend to aggregate and form large 
structures in an uncontrolled manner instead of discrete structures 
[95]
. The knowledge 
gleamed from the factors that affect DNA-AuNP interactions has led to fabrication of AuNPs 
with high DNA surface coverage, which can potentially increase the sensitivity of a detection 
system and is of valuable use in diagnostics. In Zhao and Hsing's work, they used oligo 
ethylene glycol (OEG) and salt concentration to control the loading of DNA onto AuNPs 
[96]
. 
This could give AuNPs with a low number of DNA that was amenable for the bottom-up 
nanostructure formation process, or a high DNA loading applicable for biosensing. The 
ability to tune the DNA loading on AuNPs allowed the conjugation process to be more 
elegant, and arguably increase the versatility of the AuNP-DNA conjugates.  
 2.2.3 Application of gold nanoparticles to biosensing (Plasmonic sensors) 
While AuNPs are applied many ways in biosensing, they are most often exploited for their 
unique optical properties which make them excellent components in biosensors. Usually, they 
are the transducing agent that present the readout of a bio-recognition event. Two optical 
properties that results in bulk changes in a system are the distinct spectroscopic red shift 
when AuNPs aggregate, and the quenching or restoration (depending on design) of 
fluorophores in close proximity to an AuNP. This section will focus on how these properties 
are leveraged for the detection of a number of biomarkers at the different genomic, 
transcriptomic and proteomic levels. 
  2.2.3.1 LSPR shift (Aggregation-based) assays 
AuNPs functionalized with ssDNA had been shown to be effective as nucleic acid sensors 
wherein the presence of complementary target caused the AuNP probes to aggregate. 
Typically, such sensors utilized AuNPs whose surface were saturated with DNA, and a rapid 
and distinct colour change resulted when a target molecule was present 
[66]
. One of the most 
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straightforward methods involved the use of ssDNA-saturated probes bound onto a common 
linker. The extensive network that developed in the presence of the nucleic acid target led to 
the distinct spectroscopic peak-shift to longer wavelengths, as evidenced by a red to blue shift 
in the colour of the sample. The sharp and distinct colour change was also found to be 
capable for distinguishing SNPs, and DNA-binding molecules which enhanced the colour 
change through stabilization of the aggregation network 
[91, 97]
. The combination of AuNP 
with silver NPs (AgNPs) and silver enhancement also presented a sensitive means of nucleic 
acid detection, with the scanometric method achieving low fM detection limits 
[98, 99]
.   
The scanometric technique discussed in the previous paragraph was adapted for the detection 
of mRNA samples, with the development of a mRNA detection array 
[100]
. It was reported 
that 0.5 μg of total RNA was adequate for analysis done in a timely 2 hours without 
enzymatic amplification. Furthermore, miRNA linked to prostate cancer was detected using 
the scanometric method with much superior sensitivity over conventional fluorophore-based 
systems, and with single-base mismatch discrimination abilities 
[101]
. In the technique 
developed by Chang and co-workers, AuNP hybridizing onto miRNA targets in a lateral flow 
system was used to generate a positive readout, which showed a limit of detection in the low 
fmol levels, or amol levels with silver enhancement 
[102]
.  
AuNP-based platforms working on the principle of LSPR shifts had been used for the 
detection of a number of protein biomarkers. PSA was screened by an AuNP-enhanced SPR 
sensor with 10ng/ml limit of detection 
[103]
. In another work using an AuNP-enhanced 
immuno test strip, PSA was even detected at as low as 0.2ng/ml concentration 
[104]
. In 
addition, in both studies, serum samples were successfully tested, and the potential of 
developing a rapid test system capable of point-of-care use was apparent. In the system 
proposed by Huo and coworkers, AuNPs was designed to aggregate in the presence of PSA. 
Using the DLS as platform, the size change of the system in the presence of PSA was clearly 
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distinguished from that of controls. In this work, DLS was not employed as a characterization 
tool as it is traditionally used, but as a bioanalytical device, thus showing its versatility 
[25]
. 
The biobarcode method was also employed for the detection of multiple protein targets in the 
same solution. Through the aggregation of predesigned AuNP-oligo tags upon protein 
recognition, this was presented as a sensitive and selective detection platform 
[105]
. In 
addition, SERS-AuNP systems had been used to detect various proteins such as thrombin and 
adenosine, achieving low limits of detection due in part to an in-built amplification process 
brought about by AuNPs 
[106]
.  
  2.2.3.2 FRET/ NSET-based assays 
The fluorescence resonance energy transfer (FRET) phenomenon is based on the energy 
transfer from donor dye-like molecules to its acceptor counterpart, which can result in either 
an enhancement or quenching of optical activities. FRET is the working principle in MB 
system which typically involved the use of luminescent molecules with a partner quencher. 
The fluorophore and quencher can be joined by a DNA hairpin, which keeps the two 
molecules in close proximity and in the quenched state. A typical FRET system employed for 
detection is shown in Fig. 2.3 below:  
 






The presence of a target (mRNA, in this case) opens the hairpin and restores the fluorescence 
[108]
. A distinct advantage of this method is that the targets are unlabelled, which makes it a 
more direct detection method without added processing steps. Depending on the design, the 
detection can either be a 'turn-on' or 'turn-off' system. Typically, turn-on systems are more 
sensitive and allow multiplex detections to be carried out more readily
 [109, 110]
.  
Nanoparticle surface energy transfer (NSET) refers to a similar process, but typically with 
metallic NP as the acceptor 
[111, 112]
. The energy transfer is more efficient as the effective 
NSET separation distance is longer than that of FRET. AuNP of 5-10nm had been proposed 
to be optimal quenchers, with quenching efficiency significantly superior to that of the well-
studied molecular quencher DABCYL 
[113]
. The energy transfer remained effective up to 
20nm when larger (10-50nm) AuNPs were used 
[114]
. AuNPs could also be scaffolds to carry 
multiple chemical moieties or ssDNA such as hairpins, something which traditional 
fluorophores cannot do. However, in detection systems reported in the literature, FRET and 
NSET are typically not explicitly distinguished from one another since the focus is on the 
detection outcome. 
After Krauss and co-workers reported a prototypical MB system to detect oligonucleotides in 
2002, the technique has been successfully applied to the detections of nucleic acid target like 
cDNA in a relatively sensitive (pM) manner and with good specificity, as well as 
multiplexing potentials 
[115, 116]
. Also, hairpin DNA-functionalized AuNPs were reported for 
the sensing of mRNA in melanoma cells, with the binding of mRNA targets resulting in the 
restoration of beacon fluorescence and allowing intracellular imaging 
[117]
. Mirkin and co-
workers reported on the development of the nanoflare system which essentially was an AuNP 
carrying multiple MBs specific for different mRNA targets. The system was shown to be 
selective, while exhibiting multiplex potentials, and applicable for use in live cells 
[118]
. The 
application of MBs in the detection of protein biomarkers was realized in the development of 
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aptamer beacons in which the recognition of aptamers to specific proteins resulted in the 
restoration of fluorescence 
[119]
. Aptamer beacons had been successfully utilized in the 




While there are many advantages to NP- and AuNP-based systems and that many systems 
have shown to be good for biomarker detection both sensitively and selectively, the impetus 
should always be that they could address specific unfulfilled needs in the biomarker detection 
landscape such as in area where traditionally used molecular methods fall short. In addition, 
one has to recognize that no system is perfect and there is always room for improvement even 
for as-developed NP systems. It is with these ideas in mind that the different works in this 
thesis have been developed.  
2.3  DNA 
Due to the unique and specific interaction between complementary A-T and C-G base pairs, 
the structural conformation of DNA can be analyzed on many levels. In addition to forming 
duplex of defined structures, given the (long) length of a single DNA strand, it is possible that 
there are spatial interactions, resulting in the folding of the molecule into particular 
conformations, such as DNA hairpins, or even more specialized structures such as G-
quadruplexes, which is one of the central components of this thesis and discussed in detail in 
the later sections.  
 2.3.1  Structural properties 
The genetic code is governed by the unique and specific interactions between the A, T, C, G 
and U residues, with the A-T/U and C-G base-pairing resulting in the characteristic double 
helical conformation. Hydrogen-bonding, base-stacking and electrostatic interactions then 
render stability in the sequence and resulting duplex 
[122]
. The local basepair recognition also 
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has a direct effect globally with the DNA duplex existing in the right-handed B-conformation 
or left-handed Z-conformation based on different orientations of the major and minor grooves 
[123]
. In addition, the presence of salt or ions in proximity to the DNA sequence also has a 
bearing on the duplex stability, as the strength of the interaction of ions with the various 
bases is different. This affects the localization of the ions to different parts of the double 
helix, which in turn also affects the resulting structure conformation 
[124, 125]
. All these factors 
govern the melting characteristics of the duplexes, and are of important consideration in the 
design and use of DNA-AuNP probes in the various detection systems discussed previously. 
On the other hand, the type of DNA conformation also affects its biological role 
[126]
. For 
examples, the PhoB transcription factor specifically recognizes the DNA minor groove 
[127]
. 
Specially designed small molecules like the pyrrole-imidazole (Py-Im) polyamide can also 
interact with DNA in unique and specific manner 
[128]
. For example, combinations of Py and 
Im molecules that recognize particular DNA sequence abnormalities such as A-T mismatches 
have been reported 
[129]
. The binding of the Py-Im polyamide to DNA minor groove with 
specific recognition of different sequences can bring about gene silencing activity, and 
potential anti-cancer use 
[130]
.  
 2.3.2 DNA secondary structures (G-Quadruplex) 
When four guanine bases are in a coplanar arrangement and held by Hoogsteen hydrogen 
bonds, a G-quartet is formed. When stacked together G-quartets form the G-quadruplex, 
which is stabilized by cations such as K
+ 
and other ligand molecules 
[131-134]
. In particular, 
monovalent cations in the central core of a quadruplex can coordinate to the eight carbonyl 




Figure 2.4. G-quartet formed from the co-planar arrangement of four guanine residue (left); 
Monovalent cation in the core of the quadruplex interacts with the guanine residues, and 




The structural and topological arrangement is of much scientific curiosity as the quadruplex 
can be formed in either intra- or inter-molecular format, giving rise to monomeric (single 
strand), dimeric (two strands) configurations, and more. In addition, there are many ways the 
adjacent nucleic acid can be arranged, such as in parallel, anti-parallel or hybrid 
conformations 
[136, 137]
. More importantly, it has been discovered that G-quadruplexes have 
significant physiological importance as they are found as repeat groups in telomeres, and in 
oncogenic promoter sites. The formation of the G-quadruplex is associated with the inhibition 
of telomere extension and performs a regulatory role on errant cell division 
[138, 139]
. Human 
cells have a fixed length of telomeres, which get progressively shortened with each cell cycle 
due to the non-replicable nature of the lagging strand. This functions as a cell replication 
checkpoint, with cells generally undergoing around 50 division cycles before entering 
senescence and eventual cell death 
[140]
. However, cancer cells show an overexpression of the 
telomerase enzyme, which lengthens telomeres and allows the cell to replicate indefinitely. 
But when telomeres form quadruplex structure, telomerase becomes ineffective, which 





This has prompted blossoming research on the quadruplex, such as the development of 
ligands that can stabilize these structures as anti-cancer drugs 
[142]
. 
 2.3.3 DNA architecture 
The base-pair recognition and their intrinsic stability have led to the construction of different 
structures through the design of the sequences and orientations. 3-D construction centered 
upon DNA templates created different geometries, presenting structures such as cubes, knots, 
Borromean rings and different polygonal shapes 
[143, 144]
. This was extended to scaffolds, 
larger assemblies, and also DNA origami, as presented in the article by Rothemund 
[145]
. The 
organization of DNA into assemblies was also the basis for DNA-based nanomachines, in 
which the transition of the B to Z conformation was accompanied by the displacement of the 
DNA strands, as shown by Mao and co workers 
[146]
. Specially designed and assembled 3D 
DNA tetrahedra that changed shape based on molecular signals was also reported 
[147]
. The 
process works via the DNAzyme activity and the cleavage of substrates, which resulted in 
conformational changes and was also the basis for DNA nanomotors systems 
[148]
 . 
 2.3.4  Emergent and unique DNA properties 
In addition to their structural diversity, different DNA structures exhibit unique properties. 
The DNAzyme activity was briefly mentioned in the previous paragraph. This DNAzyme 
activity was also seen in G-quadruplexes with a hemin molecule held within the matrix of the 
structure, which imparted the DNA peroxidase-like catalytic activity 
[149]
. Such DNAzyme is 




, which is accompanied by the colourless 
to green transition. Such systems had been applied for the screening of G-quadruplex 
stabilizing ligands and colorimetric detection of proteins 
[150, 151]
.   
As already mentioned in the earlier, the association of miRNA with mRNA led to the 
activation of a regulatory mechanism in which the miRNA-mRNA hybrid triggered their 
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cleaving by RNase H 
[152]
. This is yet another unique nucleic acid property be considered as a 
form of auto-catalyzed regulation. This helps in the regulation on the level of mRNA and 
ensures that gene transcription stays in a controlled manner. As a feedback mechanism, this 
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CHAPTER 3: GOLD NANOSTRUCTURES DETECTION OF A GENE 
BIOMARKER - MULTIPLEX DETECTION OF GLUCOSE-6-PHOSPHATE 
DEHYDROGENASE SINGLE NUCLEOTIDE POLYMORPHISMS 
 
3.1 Introduction  
Many genetic diseases are caused by single nucleotide point mutations, for example, cystic 
fibrosis and thalessemia 
[1]
. In particular, glucose-6-phosphate-dehydrogenase (G6PD) 
deficiency is a recessive genetic condition arising from single-base mutations in the G6PD 
gene on the X-chromosome, and affects 200-400 million individuals worldwide 
[2-4]
. It is 
estimated that 7.5% of global populations carry one or two G6PD mutant alleles with 2.9% 
being deficient for this enzyme deficiency.  It is also thought that this condition is highly 
prevalent in malaria endemic countries as it confers resistance against malaria 
[2]
. G6PD 
deficient subjects are usually asymptomatic until triggered by infections or the ingestion of 
certain food or drugs such as anti-malarial drugs. Clinical outcomes commonly described 
include neonatal jaundice and acute haemolytic anemia 
[5]
. Thus, there is a need to detect 
G6PD deficient subjects in order to avoid triggers for haemolytic anemia and use a substitute 
medication course when necessary 
[6]
. Routine screening methods typically involve 
colorimetric biochemical assays. However, while these methods are rapid and relatively 
cheap, they are qualitative or semi-quantitative and cannot identify the exact mutations 
[7]
. 
They are also not sensitive enough to detect heterozygotes where both normal and G6PD 
deficient erythrocytes are present 
[8, 9]
. Molecular diagnosis is possible through identification 
of the mutations in the G6PD gene. Such mutations have been reported at various locations of 
the gene in affected individuals, and the dominance of particular mutations is geographically-
linked. Specific mutation genotypes have been associated with different populations, for 
example, c.95A>G, c.871G>A, c.1004C>T, c.1024C>T, c.1376G>T and c.1388G>A 
mutations are especially common among the Chinese population. These mutations are 
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commonly referred to as the Gaohe, Viangchang, Fushan, Chinese-5, Canton and Kaiping 
variants respectively 
[10-13]
. Typically, molecular diagnosis for any genetic disorder involves 
either a mutation screening method followed by confirmation through DNA sequencing, or 
directly proceeding to sequencing. This is often laborious due to the experimental steps 
involved and the sequence data analysis required. A rapid approach for diagnosis is through 
genotyping for mutations common to a geographical locale, followed by subsequent testing 
for more uncommon and rare mutations if the former is not informative. Thus, given the 
clinical relevance and the complement of mutations associated with this condition, there is a 
motivation to develop a simple and inexpensive multiplex assay with direct result readout for 
large scale or population-based screening of G6PD, especially in developing countries where 
G6PD deficiency is prevalent.  
 The advent of nanotechnology has led to improvements in molecular techniques in areas 
such as sensitivity, selectivity and immediacy of readouts. Nanoparticles offer unique 
properties, such as surface plasmon resonance, and they are amenable to bio-
functionalizations, making them ideal as labelling tags or readout platforms 
[14-16]
. Mirkin and 
co-workers have developed various colorimetric assays that leverage on the spectral shift of 
gold nanoparticles as they aggregate in the presence of DNA targets 
[17]
. The readouts can 
easily be visualized by the naked eye. Further application using biobarcode assay even offers 
PCR-like performance with zM detection limit 
[17, 18]
. Control in the functionalization of 
AuNP is also described by Alivisatos and co-workers as they showed the formation of 
discrete AuNP structures bearing distinct number of single-strand DNA that is evidenced in 
transmission electron microscopy (TEM) and gel platforms 
[19, 20]
. This allows the formation 
of distinct nanostructures, as Qin and Yung have demonstrated through the use of AuNP 






This chapter presents the use different AuNP probes for detecting four characteristic G6PD 
mutations prevalent in the Asian population, namely Canton, Mahidol, Union and A+ 
variants 
[3, 24, 25]
. These probes are not only specific for a perfectly matched mutant target 
relative to the wild-type non-target, but when used in tandem, are able to discriminate 
variants in the G6PD gene. This multiplex readout is presented in a direct and unambiguous 
manner, which gives a yes/no readout for the variant nucleotide of interest, and also 
discriminates among different single base mutations through the differential mobility of the 
probes in agarose gel electrophoresis. Clinical samples were probed with different types and 
sizes of probes, and results have conformed to predicted expectations. The success of this 
technique has wider implications in the screening for disease-associated single nucleotide 
mutations and polymorphisms, and for biomarker discovery in general. This is also the first 
work in this thesis, with the detection of biomarkers beginning at the gene level. 
3.2 Experimental Section 
 3.2.1 Materials  
Hydrogen tetrachloroaurate (III) trihydrate (HAuCl4), trisodium citrate dihydrate (Na3Ct), 
tannic acid, 4,4’ (phenylphosphinidene)bis (benzenesulfonic acid), dipotassium salt hydrate 
97% (PPBS), NaCl, MgCl2, and trisborate-EDTA (TBE) buffer were purchased from Sigma–
Aldrich (Singapore). Tris buffer (pH 8) and agarose powder were purchased from 1
st
 Base Pte 
Ltd (Singapore). Modified synthetic DNA molecules (modified with or without 3’ or 5’ thiol 
end group) were purchased from 1
st
 Base Custom Oligos (Singapore). Milli-Q water with 
resistance >18MΩ/cm was used throughout the experiments. For the amplification of patient 
samples, standard PCR conditions were applied using a thermocycler (Biometra, Germany): 
Initial denaturation at 95°C for 7 min; followed by 35 cycles of 95°C for 1 min, 58°C for 1 
min and 72°C for 3 min; and a final extension at 72°C for 7 min. Amplifications were 
performed in total reaction volumes of 25μl, containing 100ng DNA, 0.4μM of forward and 
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reverse primers, 1U Taq DNA Polymerase, 0.4mM dNTPs, 2 mM MgCl2 and 1X Buffer 
(Promega, Singapore). All samples were obtained following approved institutional ethics 
guidelines and the study was approved by the Institutional Review Board of the National 
University of Singapore. 
 3.2.2 Synthesis and characterization of gold nanoparticles 
The synthesis of AuNP was based on the Turkevich protocol 
[26]
 for the synthesis of colloidal 
gold. Reaction conditions (of HAuCl4 precursor, synthesis time and temperature) were kept 
constant, while concentration of reductant (either Na3Ct only or both Na3Ct & tannic acid) 
was varied 
[27, 28]
. AuNP products were characterized first with UV-vis spectroscopy and 
transmission electron microscopy (TEM) (JEM-2100F, 200 kV, Joel). The TEM micrographs 
were analyzed with the NIH Image J software for size measurement (at least 200 particles). 
The particle size distribution were further characterized by determining their electrophoretic 
mobilities on a 3% agarose gel (5V/cm) and dynamic light scattering (DLS) (Zetasizer Nano 
ZS, Malvern).   
 3.2.3 Fabrication of gold nanoparticles-ssDNA (AuNP-ssDNA) conjugate  
  probes 
Surface passivation of AuNP with PPBS was first done for at least 4 hours followed by 
incubation with ssDNA specific for the mutant targets. 100b and 18b ssDNA-AuNP 
conjugate probes for each target were prepared. The gene sequences of all the ssDNA (both 







Union 100b probe SH-(5T)GGACATAGTATGGCTTGGGAGGCCGGTGGCACACAGGGAGGGAGG                 
GCAAAGGCCACCCCATAGCCCACAGGTATGCAGGGGCCGGCAGCTGGGCC 
Union 18b probe TCACCTGCACACG (5T) - SH    
Union mutant target CGTGTGCAGGTGAGGCCCAGCTGCCGGCCCCTGCATACCTGTGGGCTATGG
GGTGGCCTTTGCCCTCCCTCCCTGTGTGCCACCGGCCTCCCAAGCCATA 
Union wildtype target CGTGCGCAGGTGAGGCCCAGCTGCCGGCCCCTGCATACCTGTGGGCTATGG
GGTGGCCTTTGCCCTCCCTCCCTGTGTGCCACCGGCCTCCCAAGCCATA 
Mahidol 100b probe SH-(5T)TAGATCTGGTCCTCACGGAACAGGGAGGAGATGTGGTTGGACAGC                 
CGGTCAGAGCTCTGCAGGTCCCTCCCGAAGGGCTTCTCCACGATGATGCG   
Mahidol 18b probe GTTCCAGCTTCTG (5T) - SH    
Mahidol mutant target CAGAGGCTGGAACCGCATCATCGTGGAGAAGCCCTTCGGGAGGGACCTGC 
AGAGCTCTGACCGGCTGTCCAACCACATCTCCTCCCTGTTCCGTGAGGAC 
Mahidol wildtype target CAGAAGCTGGAACCGCATCATCGTGGAGAAGCCCTTCGGGAGGGACCTGC 
AGAGCTCTGACCGGCTGTCCAACCACATCTCCTCCCTGTTCCGTGAGGAC 
Canton 100b probe SH-(5T)CCAGCCCCCACCCTTTCCTCACCTGCCATAAATATAGGGGATGGGC 
TTGGGCTTCTCCAGCTCAATCTGGTGCAGCAGTGGGGTGAAAATACGCC 
Canton 18b probe AGGCCTCAGGGAG (5T) - SH    
Canton mutant target CTCCCTGAGGCCTGGCGTATTTTCACCCCACTGCTGCACCAGATTGAGCTG 
GAGAAGCCCAAGCCCATCCCCTATATTTATGGCAGGTGAGGAAAGGGTG 
Canton wildtype target CTCCGTGAGGCCTGGCGTATTTTCACCCCACTGCTGCACCAGATTGAGCTG 
GAGAAGCCCAAGCCCATCCCCTATATTTATGGCAGGTGAGGAAAGGGTG 
A+ 100b probe SH-(5T)CTCATGCAGGACTCGTGAATGTTCTTGGTGACGGCCTCGTAGACGG 
TCGGGGGCAAGGCCAGGTAGAAGAGGCGGTTGGCCTGTGACCCCAGGTG 
A+ 18b probe GAGGGCATCCATG (5T) - SH 
A+ mutant target CATGGATGCCCTCCACCTGGGGTCACAGGCCAACCGCCTCTTCTACCTGGC 
CTTGCCCCCGACCGTCTACGAGGCCGTCACCAAGAACATTCACGAGTCC 
A+ wildtype target CATGAATGCCCTCCACCTGGGGTCACAGGCCAACCGCCTCTTCTACCTGGC 
CTTGCCCCCGACCGTCTACGAGGCCGTCACCAAGAACATTCACGAGTCC 
 
Table 3.1. Sequence of probe and target oligos for Union, Mahidol, Canton and A+ SNP 
variants (the mutation is highlighted in grey). 
 
Three hours after the oligo addition, thiolated oligo-(ethylene glycol) (OEG) was added at a 
500:1 OEG:AuNP ratio. The AuNP-ssDNA probes were prepared in 75 to 200mM NaCl 
initially (depending on size of AuNP), and gradually NaCl concentration was raised to 
between 350 and 600mM (larger AuNP conjugates are generally less stable at higher NaCl 
conditions). The probes were subsequently washed in 50mM Tris and NaCl. 100b probes 
were run on a 3% agarose gel and conjugate monomers (probes bearing a single ssDNA 
strand) were recovered. 18b probes were used without prior purification. The concentrations 
of probes were estimated from their UV absorbance 
[29, 30]
. Prior to use, all probes were 
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screened using UV spectroscopy and DLS to ensure that they remain monodispersed and 
unaggregated. Probes without targets were also used as controls in subsequent tests and gel 
runs, and their monodispersity was further confirmed by the (single) band observed. 
 3.2.4 Formation of dimeric nanostructures in the presence of mutant targets  
Based on our previous work, and after optimization for different sizes of AuNP, a probe to 
target ratio ranging from 1:1 to 1:1.5 ratio was used. By default, 1 pmol of synthetic DNA 
was used as a target for all the runs. Hybridization conditions were kept at 50mM tris buffer 
(pH 8.0), 100mM NaCl and 2mM MgCl2 with the samples being heated up to 75°C and 
cooled by 0.5°C every 30 seconds. The hybridized samples were left to stand for at least an 
hour. The samples were then characterized using a 3% agarose gel (75V for 45 minutes at 
4°C). Gel images were taken using the Syngene GeneGenius UV/white light gel 
documentation system. The gel images, with a 10% enhancement of contrast, were 
subsequently analyzed using the NIH Image J software, and the density of the dimer bands 
was measured relative to that of the unbound probes control. This densitometric analysis 
provided more quantitative information on the dimer bands, and further confirmed the 
presence of the target. 
3.3 Results and Discussions 
 3.3.1 Design of detection system 
A schematic of the nanostructure formation and gel readout is shown in Fig. 3.1, where two 
AuNP-ssDNA probes (carrying 100b and 18b ssDNA respectively) hybridized to a mutant 
target sequence and formed a dimeric gold nanostructure. The successful formation of the 
structure was visualized by agarose gel electrophoresis, where a distinct band could readily 





Figure 3.1. Design of AuNP-ssDNA probe system. A 100b and 18b probe tandem would 
bind onto the same single-stranded target to form a dimer. Mutation site is located on 18b 
probe. The 3% agarose gel image showed the formation of dimers in the presence of a perfect 
matched target. In the absence of targets (probes only), no such dimer bands was observed. 
The TEM image of purified dimers is also shown. 
 
 3.3.2 Characterization of different sizes of gold nanoparticles 
The combination of water, Na3Ct and HAuCl4 are integral to the successful synthesis of 
AuNP of the desired size(s), as varying the Na3Ct:HAuCl4 ratio changes the reaction 
pathway, and in turn affects the quality of the AuNP product. As mentioned earlier in Section 
2.2.1, Peng and co workers had reported that besides acting as a reducing and capping agent, 
citrate is a pH mediator, and controlling its addition into the reaction mixture can have a 
direct effect on the synthesis outcome 
[31]
. In addition, fixing the Na3Ct:HAuCl4 ratio at 
approximately 3 produced the smallest nanoparticle size. When the Na3Ct:HAuCl4 ratio 
decreased from 3 and below, the product size were progressively larger, as the conditions 
promoted the growth of nanocrystals in the traditional route of nucleation followed by 
diffusion-controlled net growth 
[32]
. When the ratio increased above 3, there was a 
corresponding increase in product size, although the increase was more gradual. This could 
be attributed to the high citrate concentration which caused the reaction pH to be lower than 
the pH 6.5 switch point. As a result, there were changes to the structure and reactivity of the 
Au(III) complexes, with the reaction pathway instead involving nucleation, aggregation and 












the properties of different AuNP sizes, it was imperative that we could properly control the 
sizes of AuNP synthesized and replicate them at ease. Hence, we fixed the starting 
concentration of HAuCl4 at 0.1mg/ml and varied the concentration of Na3Ct, at a fixed total 
reaction volume and synthesis condition such as temperature and incubation time. Na3Ct was 
at least five times in excess of HAuCl4. Through controlling the relative concentrations of 
HAuCl4 precursor and reductant, the resulting AuNP showed a size range of 15nm to 30nm. 
To achieve AuNP sizes of 12nm or lower, a combination of Na3Ct and tannic acid was used, 
with 9nm AuNP being the smallest synthesized. Size measurement via TEM and DLS further 
verified the results (Fig. 3.2 & 3.3).  
 
Figure 3.2. TEM micrographs and gel image of 6 different sizes of AuNP (9, 12, 15, 17, 21 





Figure 3.3. Particle distribution of different sizes of AuNP using dynamic light scattering. 
(a)-(f) refers to AuNP sizes of 9, 12, 15, 17, 21 and 27nm respectively.  
  
The synthesized AuNP showed a narrow size distribution with the standard deviation within 
10% the average particle size. The DLS readout also showed that each synthesized size 
presented a peak position that is distinct from that of the other sizes. Under agarose gel 
electrophoresis, the as-synthesized AuNP of different sizes exhibited the mobility 
corresponding to particle size, with larger particles showing slower mobilities than their 
smaller-sized counterparts. The mobility differentiation among all particle sizes subsequently 
allowed us to use electrophoresis as the readout platform. The size range was also adequate 
for multiplex detection scheme as the mobilities of different size bands were visually 
distinguishable. 
 3.3.3 Formation of conjugate probes and discrete nanostructures with different 
  sizes of gold nanoparticles 
Care was taken in the probe fabrication process since inherently AuNPs are sensitive to 
environmental conditions such as Na
+ 
levels, which might bring forth aggregation. Thus, for 
the timely fabrication of the desired conjugate probes, addition of NaCl was carefully done, 
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for it is paradoxically known that a higher NaCl can enhance DNA binding onto the AuNP 
surface while at the same time, promote clustering of AuNPs and eventual aggregation, 
handicapping the nanostructure formation 
[33]
. In our case, the ssDNA conjugation protocol 
was optimized for all the AuNP sizes used, especially the larger-sized AuNP particles which 
were more susceptible to aggregation at high salt loadings relative to their smaller-size 
counterparts. This ensured the efficient hybridization of probes to the targets without 
interference of salt-induced clustering of probes or formation of non-specific nanostructures.  
We first used the Canton G6PD point mutation, which showed a G > T mutation, as a proof-
of-principle for the methodology. The aim was to investigate the ability of the AuNP probes 
to form dimers, as well as the relative mobilities of the nanostructures. Different sizes of 
AuNP (8.5, 11, 14, 20 and 25nm) were conjugated to ssDNA specific to the mutant Canton 
variant. Probes bearing single DNA strand were recovered from the agarose gel to ensure 
dimer formation and not other nanostructures. After optimization of hybridization conditions 
for each of the sizes, dimers were successfully formed and presented as distinct dimeric 
bands on the gel platform (Fig. 3.4).  
 
Figure 3.4. Dimer formation with 8.5, 11, 14, 20 and 25nm AuNP (with Canton variant as 
the model) in 3% agarose gel (75V, 60 min). Target loading was 1pmol, and the amounts 
Canton mutation-specific probes used were varied to give optimal observation of the dimer 
band. Higher order multimer bands were attributed to the unpurified 18b probes, some of 
which may carry more than one ssDNA per AuNP and led to the formation of not just dimer, 




The 8.5nm 18b and 25nm 100b probes were used as the upper and lower limit controls as the 
former would show the greatest mobility and the latter the least mobility amongst the probes. 
Thus, they served as reference points for evaluating the mobilities of the unbound probes and 
dimer bands when targets were present. All the unbound probe bands were localized within 
these two reference bands, with the dimer bands showing a slower mobility behind the 
unbound probes bands. Potentially, the formation of dimers would not only provide a yes/no 
readout with regard to the presence of a DNA target, but also discriminate between different 
mutations due to the respective dimers being presented at distinct locations on the gel. Higher 
order bands which migrate at slower mobility than the dimer bands was formed due to 
multiple ssDNA strands conjugated on the 18b AuNP probes. Since 18b ssDNA is too short 
to induce sufficient electrophoretic mobility difference, AuNP probes with different number 
of ssDNA strands could not be resolved into distinct gel band during AuNP-ssDNA probe 
fabrication, thus no purification was done prior to use. Instead, the number of 18b ssDNA on 
the 18b probes was only adjusted through careful stoichiometric control, such that dimers 
would still be the dominant population in the presence of complementary target DNA, but the 
presence of dimer or higher order–mer bands was still indicative of the presence of target 
DNA.  
In addition, contrary to our previous work where thiolated 5-thymidine (5T) was used in the 
preparation of the conjugate probes, this study showed that OEG was as good a passivating 
agent as 5T while being only a tenth in cost. OEG was able to compete with thiolated ssDNA 
and allowed both the 100b and 18b ssDNA coverage on the AuNP to be kept low, thus 
favouring the formation of discrete conjugates with low ssDNA loading 
[34]
. From the 
hybridization studies, probe-target binding was just as effective, which suggested the OEG-
coated surface was non-interacting and kept the probe ssDNA extended outwards and not 
collapsed onto the AuNP surface, hence facilitating the hybridization process. 
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 3.3.4 Multiplex detection with discrimination between mutant and wild-type 
  targets, and across different point mutations 
AuNP-ssDNA probes for the four different variants (Union, Mahidol, Canton and A+) were 
fabricated and the dimeric nanostructures reflecting positive readouts were found to exhibit 
distinct electrophoretic mobilities. As seen in Fig. 3.5 below, the four variants were queried 
over 8 AuNP sizes, and dimer bands were observed only for the mutant targets to which the 
probes were perfectly complementary. The wild-type sequences that contained a single base 
difference did not produce any dimer bands. 
 
Figure 3.5. Multiplex detection of four variants (Union, Mahidol, Canton and A+) 
complement on a 3% agarose gel. For each mutation type, the same quantity of the probes 
specific to the particular mutation was used to detect mutant and wild-type targets which 
showed a single base difference. mut: mutant (perfectly matched) target, expected to produce 
dimer bands; wt: wildtype (mismatched) target, not expected to produce dimer bands. 
 
The mismatch site, being located on the shorter 18b AuNP probe, was affected by the 
electrostatic-steric effect exerted by the nearby AuNP and this destabilized the 
complementary binding of the probe for the target, which had an overlap of only 13 bases. 
Despite different sizes of AuNP exhibiting varied surface charge densities, the electrostatic-
steric effect was still significant in bringing about the desired discrimination property. A 
single base mismatch was enough to destabilize and dissemble any nanostructure formed. 






were distinct from one another. Although the probes carried ssDNA of the same length, the 
difference in the AuNP sizes for different mutant targets resulted in the differential mobilities 
observed. This was attributed to the mass being an important property which controlled the 
particle mobility on a gel platform, with the larger AuNP probes exhibiting slower dimer 
movement 
[35-37]
. This provided an added level of discrimination for different sequences, as 
each was expected to have a unique position based on the sizes of the AuNP particles. In this 
particular case, the spatial multiplex detection of different G6PD variants discriminated a 
mutant sequence not only from its wild-type counterpart, but also across different point 
mutations through a simple and direct observation of the mobilities of the AuNP probes 
across lanes. A positive readout would be expected in relation to the presence of the specific 
dimer bands as well as its relative position to its counterparts.  
While we have tested 8 AuNP sizes from the 7 to 25nm range, it is possible to include 
additional AuNP sizes as small as 5nm and up to 40nm, with each size used to detect for a 
specific mutant variant of the G6PD gene. This will be especially useful to simultaneously 
cover screening of other less common point mutations in the G6PD gene. This, coupled with 
the developed procedure of probe fabrication, target hybridization and visualization as 
described in this study, offers a potentially powerful multiplex detection method for G6PD 
screening of known mutations in a population. 
 3.3.5 Querying of clinical samples using different sized probes 
To validate the above approach, clinical samples from G6PD deficient patients were analyzed 
using the different types of AuNP probes. Four different patient samples – two with the 
Mahidol mutation (M1 and M2) and two with Canton mutation (C3 and C4) were obtained 
with informed consent and IRB approval. The genomic DNA samples were PCR amplified, 
purified, and subsequently detected by the respective Mahidol and Canton probes. From Fig. 
3.6, when queried with their specific probes, the Mahidol (with 11nm probes) and Canton 
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(with 15, 17 and 20nm probes) patient samples all exhibited dimer bands. When the target 
was absent, no dimer band was observed.  
 
Figure 3.6. PCR-amplified samples from 4 patients (2 with Mahidol mutation, termed M1 
and M2; and 2 with Canton mutation, termed C3 and C4) were received. The patient samples 
were queried with the respective mutation-specific probes (11nm Mahidol probes for M1 and 
M2; 15nm, 17nm and 20nm Canton probes for C3 and C4). All the patient samples were 
expected to exhibit dimer bands when tested with their respective probes. The readout was 
further characterized via the density of the dimer bands relative to the unbound probes. In the 
absence of targets, no dimers should be observed. 
 
The observations were also semi-quantified via the density of the bands, which took into 
account the intensity and area of the bands, and the dimer bands density were approximately 
10 to 20 percent that of the unbound probes. The densitometric analysis provided a semi-
quantitative assay for confirming the presence of the dimers (and target). The dimer bands, 
though less dense than their synthetic target counterparts, were easily detected by the naked 
eye without the need for additional instruments. Fainter bands were observed since the 
clinical PCR amplified samples were long duplex DNA and unlike the single-stranded 
synthetic DNA targets used in the previous sections. Given that the duplexes are typically 
more than 120 bases in length while the 18b probes have only 13 complementary bases to the 
target, the tendency for the target duplex to rehybridize with its complementary strand is 
higher. Thus it was necessary to include an annealing step such that duplexes would 
dehybridize and the target strands be available for binding with the AuNP probes, and all four 
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clinical samples were successfully detected. We have shown that different sizes of probes, 
ranging from 11 to 20nm, were equally capable of detecting the Canton and Mahidol clinical 
samples, hence validating the multiplex detection proposed. Potentially, this can be a useful 
technique for easy and direct screening, especially at the clinical setting for precise detection 
of common G6PD mutations. 
3.5 Conclusion 
Given the need for a simple, direct system for the detection of multiple nucleic acid targets, 
we have developed a AuNP system which, through the formation of distinct structures from 
different sizes of AuNP, can be clearly visualized on a gel platform. Wild-type and single-
base mutant sequences were discriminated, as well as across variants, and this technique was 
further validated using clinical samples. The ability to detect the read-outs from the AuNP 
hybridization by direct visualization from a gel-based assay makes this a simple and 
inexpensive method. Our method could potentially be applied for screening other pathogenic 
point mutations in disease genes as well as for genotyping common single nucleotide 
polymorphisms used as markers for disease association studies in disease gene discovery. 
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CHAPTER 4: GOLD NANOSTRUCTURES DETECTION OF RNA BIOMARKER - 
GOLD NANOPARTICLE-DYNAMIC LIGHT SCATTERING TANDEM FOR THE 
RAPID AND QUANTITATIVE DETECTION OF THE LET7 MICRORNA FAMILY 
  
4.1 Introduction  
In this section of the thesis, we will focus on the discussion of the detection of microRNA, a 
significant component of the transcriptome, with particular focus on an AuNP-DLS tandem 
for the detection of let7. Similar to the detection concept presented in Chapter 3, but unique 
in the platform used and design motivations, two or more AuNP-DNA probes designed to 
recognize specific let7a/f/g sequence were used to form a nanoassemblies of the dimeric type, 
and higher-order structures. The controlled growth of the system is transduced as a signal on 
DLS, which provides information on the size change of the system and the detection of the 
specific let7 miRNA. 
The discovery of microRNA as a key cog in the cellular machinery has prompted blossoming 
research to understand and validate their actions, and also to determine the exact role that 
miRNA play in cellular regulation and disease pathogenesis 
[1-3]
. Amongst these endeavors, 
the most basic and yet outstanding need is to be able to detect for the miRNA in the first 
place. As miRNA levels fluctuate widely depending on cellular conditions, the ability to 
present readouts that distinguish clearly the normal and up-/down-regulated status of the 
miRNA is a criterion that biosensors need to meet 
[4,5]
. In addition, given the short length 
(~22 bases) of miRNAs and the minimal sequence variations among close members of the 
same family, such as that of let7 miRNA, the ability to accurately discriminate different 
members of the family is another challenge imposed upon the detection system. This is 
especially important as single base difference in miRNA sequence can have different impacts 
to the pathogenesis of a disease 
[6]
. While established molecular techniques are advantageous 
in many ways, they still fall short in one or more of the criteria already discussed. Northern 
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blotting, whose sensitivity and specificity was improved through the use of locked nucleic 
acid (LNA) probes, still requires long processing time (at least 4 hours in ideal cases) and 
throughput is low 
[7,8]
. Microarray-based miRNA detections, while capable of screening a 
large number of miRNA targets in a single run, always suffer from cross hybridization, a 
problem that is aggravated by the short-length miRNA targets, and stringent washes or the 
use of LNA probes is needed to minimize non-specificity 
[9,10]
. In addition, microarray 
detection requires fluorescent labelling of the miRNA targets, which introduces additional 
experimental steps and complicates the detection process 
[11]
. qRT-PCR has shown to be a 
very sensitive method for miRNA detection due to the technique inherent amplification 
property, and this  ability to analyze low quantities at even few copies of targets has seen 
qRT-PCR becoming the diagnostic of choice, especially when involving valuable patient 
samples 
[12,13]
.  A key stumbling block of this technique, however, is the very short length of 
the mature miRNA that requires specially designed primers. The processing of the data is 
also time-consuming, which complicates the whole detection process 
[14]
. A simplified and 
direct detection method with minimal sample handling or label-free can lead to a more 
efficient detection outcome 
[15]
. 
Engineered nanoparticle (NP)-based detection platforms can address many of the issues 
aforementioned, while maintaining good sensitivity, selectivity and accuracy. Gao and co-
workers have devised many different platforms, ranging from RuO2 to OsO2, to detect 
miRNA via the catalytic degradation of substrates such as H2O2, and successfully detected as 
low as fM miRNA 
[16,17]
. Recently, the same group has reported a new enzymatic method that 
is combined with isothermal amplification to achieve sub-femtomolar miRNA sensitivity 
[18]
. 
Also, Kelley and co-workers described the use of a multiplexed electronic chip that gives a 
catalytic readout for the ultrasensitive detection of miR-21 to as low as aM levels 
[19]
. The 
detection of miR-21 through an electrochemical turn-on system has also been reported to 
 53 
 
achieve high sensitivity of 6fM and a large dynamic range (0.01 to 700pM) through a series 
of amplification steps 
[20]
. While sensitive, these platforms are largely focused on improving 
the limit of detection of the current state of the art but do not fully address other areas of 
concern. For example, these systems might be complicated to operate while it takes a number 
of extended steps before the final readout can be achieved, which generally makes them less 
amenable for use. Other optical NP techniques have provided more direct, rapid and easy to 
interpret readouts, as seen in the use of silicon NPs in an array format to detect ssRNA 
binding via the changes in SPR signal 
[21]
. The decrease in the fluorescence emission of silver 
nanoclusters was also found to be applicable for miRNA detection. Despite having not as low 
a detection limit as the various systems already discussed, the optical detection process is 
simple and readout is rapid (<1h) 
[22]
.  
Owing to the distinct and tunable optical properties, AuNPs have been utilized in many 
detection systems. In particular,  AuNPs show large scattering cross section that is 10
5 
times 
that of fluorescein and 10
3 
times stronger than polystyrene beads 
[23]
. This had led Huo and 
co-workers to develop a AuNP aggregation based detection assay measurable via the DLS 
platform (or as known as NanoDLSay) 
[24,25]
. While working on similar aggregation principle, 
the DLS detection system is based on the absolute change in the size of AuNP aggregates 
from tens to hundreds of nanometers, which is different from normal colorimetric systems 
that are based on plasmon red-shift. Furthermore, the DLS method is more sensitive with 
multiple orders of magnitude better sensitivity than the colorimetric systems (without 
amplification) which also requires an appreciably large amount of targets in order for the 
plasmon red-shift to be noticeable 
[24,26,27]
. Less probes are also required for DLS-based 
systems. This aggregation phenomenon has led to the development of other similar platforms 
whose telling readout is AuNP size change from aggregation. Examples include the use of 




. Despite numerous advantages, the limitations of aggregation-based systems is also 
apparent: AuNPs can aggregate due to external perturbations such as salt conditions, pH, 
temperature, and lead to aggregations in the absence of targets and false positive readouts. 
This prompted the need for the size selection of AuNPs used and the proper modifications of 
their surface to ensure colloidal stability 
[29-31]
. In addition, the size of aggregate cannot be 
easily controlled and the populations can vary widely. In a size-based detection system via 
DLS, this limits the quantification ability of the detection system. 
Here, we sought to leverage on the AuNP-DLS tandem for the detection of the let7 miRNA, a 
valuable biomarker. However, instead of following the aggregation-based approach, we 
focused on the formation of defined AuNP nanoassemblies including the formation of NP 
dimers, trimers and higher-order -mers to indicate the presence of the target miRNA, without 
causing systemic aggregation. In so doing, the sensitive detection of AuNP and nanoassembly 
on DLS was achieved at conditions that ensured that the AuNPs were stable against 
aggregation. The average size of the system showed a positive correlation to the amount of 
miRNA target present, and was found to be sensitive, selective, with a definite readout 
achieved as quickly as 5 minutes. 
4.2 Experimental Section 
 4.2.1 Materials 
Hydrogen tetrachloroaurate (III) trihydrate, trisodium citrate dihydrate, tannic acid, 4,4’ 
(phenylphosphinidene)bis (benzenesulfonic acid) dipotassium salt hydrate 97% (PPBS), Tris 
buffer (pH 7), NaCl, MgCl2, and trisborate-EDTA (TBE) buffer were purchased from Sigma–
Aldrich. Synthetic DNA molecules (with either 3’ or 5’ thiol modifications) and miRNA 
were purchased from Integrated DNA Technologies Pte Ltd. Oligo-etheylene glycol (OEG) 
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was purchased from Sigma-Aldrich Co. Milli-Q water with resistance >18MΩ/cm was used 
throughout the experiments. 
 4.2.2 Design of miRNA sequences and detection concept 
The sequences of different chosen members of the let7 miRNA family (a, f and g, which 
showed single or dual base differences) were obtained from an online library miRBase. Each 
of the let7 miRNA is 22 bases long. Two complementary 18 base-long probes were designed 
to bind to the target miRNA from both the 5’ and 3’ ends respectively, with an AuNP located 
at the other end, thereby achieving a sandwich structure (the sequences of the miRNA and 
probes is shown in Table 4.1 below. 
Let7a sequence UGA GGU AGU AGG UUG UAU AGU U 
Probe L7a-1 for let7a 3’  (SH) – TTT TTT TAC TCC ATC ATC 
Probe L7a-2 for let7a 5’  (SH) – TTT TTT TAA CTA TAC AAC 
Let7f sequence UGA GGU AGU AGA UUG UAU AGU U 
Probe L7f-1 for let7f 3’  (SH) – TTT TTT TAC TCC ATC ATC 
Probe L7f-2 for let7f 5’ (SH) – TTT TTT TAA CTA TAC AAT 
Let7g sequence UGA GGU AGU AGU UUG UAC AGU U 
 
Table 4.1. Sequence of miRNA (let7a, f and g), and probes used to detect for let7a and let7f. 
 
Two AuNP conjugates binding to a complementary target nucleic acid results in the 
formation of a dimer assembly. As a proof of concept, two 11nm AuNP probes, each carrying 
a single strand of 80b ssDNA, were first fabricated and purified using gel electrophoresis. 
When two such probes were used to detect the complementary ssDNA target, only the dimer 
assembly could be formed. As shown in Fig. 4.1 below, there was a distinct right shift when a 




Figure 4.1. Graphs showing the size distribution readout of monomeric and dimeric AuNP 
assembly, as observed on the DLS. Upon binding of two AuNP probes onto a ssDNA target, 
a distinct peak shift was exhibited. The increase in size and scattering cross section is 
attributed to an additional bound AuNP. 
 
Since the DLS platform is well utilized for the characterization of NPs and is very sensitive to 
size changes in the nanometer dimension (1-2 CV% error for the Malvern ZS90 system) 
[32]
, 
the single AuNP (monomer) to dimer assembly transition was found to result in an 
observable increase in size distribution, which signified the presence of the 100b target. And 
further binding of more targets and probes was found to lead to a more extensive assembly 
network and size increase. 
 4.2.3 Fabrication of gold nanoparticle probes 
11nm AuNPs were synthesized via citrate and tannic acid reduction, and capping, of the gold 
precursor, as adapted from processes described in literature 
[31,32]
. Synthesized AuNPs were 
characterized using UV-vis spectroscopy (Varian Cary 50Bio), transmission electron 
microscopy (TEM, JEOL JEM-2100F, 200 kV) and DLS (Nano ZS Zetasizer, Malvern). The 
overnight stabilization of AuNPs with PPBS was followed by the addition of probe ssDNA, 
and subsequently the gradual increase of Na
+ levels, as described in our group’s previous 
11nm monomer probes bearing single ssDNA 
(absence of target DNA) 
11nm monomer (with target DNA) 
 







. After washing with 50mM Tris and NaCl, the as-prepared 5’ and 3’ probes were 
ready for use in the detection of miRNA.  
 4.2.4. DLS Detection  





The mixture was left on a shaker, and the contents were withdrawn into disposable plastic 
cuvettes and diluted to final volume of 400μL with 50mM Tris and NaCl buffer for DLS 
measurement at desired time intervals. With a 60 second equilibration time, and following the 
instrument calibration and optimization of detection conditions, 12 to 15 runs (each taking 10 
seconds) per measurement was carried out. The instrument measures the scattered light 
intensity of the tested samples, and provides the size distribution of the sample based on 
intensity, volume and number basis, with intensity being the primary readout and the other 
two being derived values. In this work, all our measurements were intensity-based readout as 
the scattering intensity of the AuNP assembly changed through miRNA binding. The size 
distribution results were then exported, followed by data processing and normalization. The 
mean size of the system provided the basis of comparison between the different experimental 
conditions. At least 3 separate tests were done for each experimental condition, and the 
results were compared using Student’s t-test for statistical significance.  
 4.2.5 Variation of probe types and experimental conditions 
Probes with different ssDNA loadings (2x, 5x and 10x) were investigated for DLS readout 
signal optimization. While it might be intuitive that a probe carrying more ssDNA binds more 
readily to target miRNA, it was also disadvantageous in that with excess binding sites, 
nanoassemblies may not be formed easily. The increased binding sites could also aggravate 




conditions were also investigated for 
their roles in particle size change and aggregation tendency. The Mg
2+
 level was varied (at 2, 
 58 
 
10 and 20mM) at both 100mM and 500mM Na
+
 concentrations. The DLS protocol remained 
the same throughout the different testing. 
4.3 Results and Discussions 
 4.3.1 Gold nanoparticle – DLS tandem for detection of let7 miRNA  
Let7 was used as the biomarker target in our study as it exhibits tumour-suppressor functions, 
and whose regulation is found to have significant impact in a variety of cancer types. Probes 
L7a-1 and L7a-2 sandwiching let7a at the 5’ and 3’ ends respectively were fabricated. 
Through stoichiometric control, the average loading was 2 ssDNA per AuNP, which should 
result in the formation of predominantly dimer and some trimer assemblies in the presence of 
let7a. This was unlike the typical AuNP probes in colorimetric and aggregation-based 
systems whose surface are saturated with DNA. As shown in Fig. 4.2, after incubating L7a-1 
and L7a-2 with 1 pmol of let7a for 2 hours, a distinct peak shift of 10nm size increase was 
observed when compared with probes without let7a target addition.  
 
Figure 4.2. Graph showing the DLS size change when probes specific for let7a were used to 
detect specific target (1pmol let7a). Distinct peak shifts were observed only when let7a was 
present. In the absence of target or when M18, an unrelated target is added, negligible peak 
shift was presented. 
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In the case of 1 pmol M18, a sequence non-complementary to the probes and used as a 
control, no peak shift was observed. Furthermore, when the probes were incubated with 1 
pmol each of let7a and M18, a peak shift was observed once again. This shows that the 
presence of the let7a miRNA is the cause of the peak shift, and our probes exhibited good 
selectivity. When the sample with AuNP probes and let7a was viewed using TEM (Fig. 4.2) , 
a significant proportion of particles were in the form of dimers and trimers with some 
tetramers. In contrast, the sample with probes only showed mostly unbound or monomer 
particles and a few scattered dimers. The presence of the scattered dimers can be attributed to 
non-specific hybridizations between the probes, a known phenomenon reported in literature 
[33]
. This is in contrast to the AuNP before let7a addition, which existed mostly as single 
unassembled NP. Fig. 4.3 shows that probes passivated only with oligo-etheylene glycol 
(OEG) without ssDNA complementary to let7a did not exhibit any significant peak shifts 
when let7a was added (at 1 pmol and 10 pmol level). This further confirms that only 
fabricated probes carrying sequences complementary to let7a are able to elicit a positive 
readout and show a distinct peak shift. 
 
 
Figure 4.3. When probes not conjugated with sequences specific for let7a were tested with 
let7a, no peak shift was observed, even at high loadings (10pmol) of let7a. 
Probes (OEG-passivated 
without ssDNA conjugated) 
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When the probes only and probes with let7a were studied with UV spectroscopy (Fig. 4.4), 
identical readouts were obtained with a single peak observed at 520nm that is characteristic 
of dispersed AuNPs, and the nanoassembly formation was not discernible.  
 
Figure 4.4. UV absorbance spectra of probes-only and probes-with-let7a (1pmol and 
10pmol) systems. Identical spectra were observed with single absorbance peak at 520nm for 
all three cases. 
 
This further demonstrates the advantage of using DLS over other conventional techniques 
which are more suited for characterizing large scale AuNP aggregation. While it was reported 
that an estimated initial 11-particle aggregation threshold is required for the clearly visible 
spectral shift and colour change in typical colorimetric sensing systems 
[34]
, DLS describes 
such clustering phenomenon more sensitively given that it can readily distinguish between 
monomers and dimers, and is readily applicable for the detection of more subtle AuNP 
assembly that do not exhibit aggregation. Expectedly, the amount of probes required could be 
kept low (at least 2 orders of magnitude less than the colorimetric assay developed by Mirkin 
and co-workers) since DLS is more sensitive 
[35]
, and consequently the DNA loading on 
AuNP is minimized (2-5 DNA molecules per AuNP shown in our work instead of saturating 
the AuNP surface with DNA), which allowed more economical use of DNA probes. 
The kinetics of hybridization process was investigated with DLS over a two hour period. A 
comparison with and without let7a was done using the same probes and binding conditions. 
Probes-only 
Probes + 10 pmol let7a 
Probes + 1 pmol let7a 
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As seen from Fig. 4.5, the addition of miRNA let7a into the AuNP probes exhibited 
discernible size increase compared with the probes-only samples at the 5-minute mark.  
 
Figure 4.5. Graph presenting the time study of the probe-let7a hybridization process, as 
observed on the DLS platform.  
 
On one hand, this suggests a fast initial rate of probe-target hybridization which can be 
attributed to the short miRNA length. Also, with the design of the system, AuNP probes 
binding to the miRNA target formed nanoassemblies that led to more intense signals, and this 
meant that once a proportion of targets were bound by probes an appreciable readout would 
be elicited. The size difference only got larger and was largest at the 100 minutes when the 
probes with let7a exhibited 25% increase in size. Thus, the readout at the 120-minute mark 









levels, and probe loadings on  
  hybridization and miRNA detection 
Due to the inherent short length of let7a (22 bases long) and the nature of our detection 
design, the resulting nanoassemblies formed in the presence of AuNP probes may be 





, the ssDNA probe bound on the 3’ end of let7a has a theoretical melting 
temperature of 26.8˚C (Table 4.2).  
 
Table 4.2. Table showing the changes in the stabilities of the hybrids as the hybridization 
conditions (NaCl and MgCl2 levels) are changed.  
 
This meant that even if hybridization successfully occurred, the let7a-bound probes may still 
readily dehybridize. Thus, to enhance the stability of the DNA-miRNA duplex as well as the 




levels on the melting 
temperature of the hybridized let7a duplexes (without AuNPs) was first investigated. As 
shown in Table 4.2, when the Na
+ 
level was raised to 500mM and 1000mM, the melting 
temperature increased beyond 30°C, giving more stable duplexes. Similarly, at 10mM and 
  Melting temperature (
o
C) 
  Probe binding to let7a at 3’ end Probe binding to let7a at 5’ end 
Initial 
Condition 
0.002M MgCl2  
0.1 M NaCl 
26.8 31.9 
Condition 2  0.002M MgCl2  
0.5 M NaCl  
30.3 35.2 
Condition 3  0.002M MgCl2  
1.0 M NaCl  
32.5 37.0 
Condition 4  0.01M MgCl2  
0.1 M NaCl  
30.2 35.0 
Condition 5  0.02M MgCl2  






 levels, there was an increase in melting temperature. However, we are mindful 
that the colloidal stability of AuNPs are generally sensitive to high ionic environments and 
might aggregate, which is not desirable in this DLS detection system and should be prevented 




levels. Thus, buffer conditions were studied to ensure that 
AuNP probe-miRNA target hybridization was enhanced, and resulting in stable 
nanoassemblies. 




 (Fig. 4.6A), all 
three types of probes (2x, 5x and 10x ssDNA loaded per AuNP) exhibited similar size 
relative to the probes-only system (control) at low let7a levels (10, 100 fmol), and a size 
increase (10 nm) at the higher level of 10 pmol let7a for the 2x loaded probe. Aggregation 
was observed for the 5x and 10x loaded probes at 10 pmol let7a. These data were not 




        
        
Figure 4.6. Graphs showing the size change of three types of probes (with 2x, 5x and 10x ssDNA loaded per AuNP) over 
a range of let7a, with the control being probes-only systems. (A) and (B) indicate 100mM Na
+
 hybridization condition, 
with 2mM and 20mM Mg
2+ 
respectively. (C) and (D, with insert) show 500mM Na
+ 










levels were increased since 




 levels. Fig. 4.6B shows that 
100mM Na and 20mM Mg
2+ 
level resulted in larger overall nanoassembly size (>5nm) in the 
presence of let7a (>10fmol) for all three types of probes, with the 10x loaded probes showing 
the greatest degree of size increase across the different levels of let7a. However, the 5x and 
10x loaded probes were also more prone to aggregation at higher Mg
2+
 concentrations, which 





4.6A). In Fig. 4.6C, with Na
+ 
increasing from 100mM to 500mM and Mg
2+ 
 being unchanged 
at 2mM, the size change across different let7a levels was not clearly discernible for all the 




combination (Fig. 4.6D), the size increase with respect to let7a level exhibited the best trend, 
with the 5x and 10x loaded probes showing more obvious size change in response to let7a 
added. There was discernible size change at 100fmol, which was even more distinct with 







 condition due to the good size-change observed in response to 
the presence of miRNA and their relative stability (less prone to aggregation). Results for 
higher Na
+ 
conditions were not shown as the system was more unstable and aggregated 





Figure 4.7. Image of cuvettes (left) showing probes in an un-aggregated state in the absence 
of miRNA target and that which have aggregated at high target loading. Similar results were 
observed on the DLS, with unaggregated samples showing a smooth, wide curve at smaller 
size range (<200nm), while aggregated samples presented a thin, sharp peak at close to 
1000nm size range. 
 
 4.3.3 Readout-concentration relationship (let7a and let7f) 
A quantitative study was carried out over 10 to 5000 fmol of let7a, and the concentration-





. A linear regression R
2
 value of 0.962 was obtained, showing good linear proportion 
correlation in the concentration-readout data.  
 
       1                        2                                   
Cuvette 1 – Probes only  
     (Un-aggregated) 




Figure 4.8. Concentration–response curve for (A) let7a and (B) let7f respectively. The 
probes were queried over a 10 to 5000fmol miRNA range, and a good correlation was 






The wide range of concentrations demonstrates the feasibility of applying this detection 
system for wide dynamic range detections. To further affirm the chosen hybridization 




) and to validate the detection 
technique, AuNP probes targeted against let7f miRNA were also fabricated. Similarly, the 
probes were tested over 10 to 5000 fmol let7f miRNA, and again a good correlation R
2
 value 
of 0.986 was obtained (Fig.4.8B). These two sets of let7a and let7f detection results show that 
the DLS-based detection technique can detect the desired target in a quantitative and sensitive 
manner. The limit of detection (background plus three times standard deviation of blank) was 
calculated to be at 100fmol. 
 4.3.4 Selectivity of gold nanoparticle probe system 
The aim of our study here is not only to detect the presence of miRNA, but also to 
discriminate among different members of the let7 family (many of which show only minimal 
sequence difference), as individual members are found to be specifically implicated in 
different disease conditions and the selection of one member over others in a detection 
process can allow disease conditions to be better characterized 
[36]
. 
The selectivity of the DLS detection technique was investigated by querying probes specific 
to let7a miRNA with let7f and let7g. The let7f miRNA differs from let7a by a single base 
(AG) in the middle of the sequence, while let7g contains two bases difference from let7a 
(Table 4.1). From theoretical predictions of the melting point stabilities of crosshybridizing 
duplex as presented in Table 4.3, we can see that the most stable duplex is formed when the 





Probe let7 target/ delG 
let7a let7f let7g 
L7a-1 -16 kcal/mole -16 kcal/mole -5.24 kcal/mole 
L7a-2 -14.86 kcal/mole -13.52 kcal/mole -6.2 kcal/mole 
L7f-1 -16 kcal/mole -16 kcal/mole -5.24 kcal/mole 
L7f-2 -13.52 kcal/mole -15 kcal/mole -6.2 kcal/mole 
Table 4.3. Table showing the free energy of the system (indicated by the delG value) when 
different probes are cross-hybridized with the respective let7 targets. 
 
In the presence of a single base mismatch (L7a-2 against let7f, and L7f-2 against let7a), there 
is a decrease of in the Gibbs free energy of the system as indicated by the delG value (more 
stable duplex giving a more negative value). This difference was more obvious in the case of 
let7g when there are two or more bases mismatches. Note that these theoretical values were 
computed without considering the effect of the nearby AuNPs, which may likely further 
destabilize mismatched duplexes, thus enhancing the selectivity of the system.  
For the study, 1 pmol of let7a, let7f and let7g were added separately to wells containing L7a, 







4.9 shows that probes incubated with let7a exhibited the greatest size change, with an average 
size of approximately 60nm. This is in significant contrast to the probes-only samples which 




Figure 4.9. Graph showing the detection of let7a, 7f, 7g, as well as a let7 a/f/g cocktail using 
probes specific for let7a only. The results were treated statistically and the p-values are as shown 
(p-value < 0.05 indicates the data sets are significantly different). 
 
The let7f samples gave an average size of 30nm, which was not unexpected as the single base 
difference would still lead to some degree of hybridization. However, due to the inherent short 
sequence and lower stability of nanoassemblies with mismatched sequences (Table 4.3) as well 
as the influence of the nearly AuNP, a single base mismatch would destabilize the nanostructure 
which resulted in relatively low non-specific hybridization. This was even more apparent for the 
let7g samples which exhibited similar size as the probes-only samples. Furthermore, since the 
detection of miRNA in clinical samples may involve complex cellular constituents with different 
miRNAs or multiple members of a family, we also queried the L7a probes with a mixture 
containing 1 pmol each of let7a, let7f and let7g. The results from Fig. 4.9 showed that the probes 
could successfully detect the let7a present despite the presence of other sequences. The size 
P < 0.05 
P < 0.05 
P > 0.05 
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change was comparable to the results of the let7a-only samples, which reinforced the selectivity 
of the technique. Statistical analysis of the repeated experiments showed that the size increase in 
the let7a samples was significantly different from the let7f and 7g samples (p-value < 0.05), 
while the let7 miRNA mixture (let7a, let7f and let7g) results did not show any significant 
difference from the let7a-only samples (p-value > 0.05). 
Finally, let7f probes (L7f-1 and L7f-2) were used to confirm the selectivity of the AuNP probes. 
Similar to the results with the let7a probes, the selectivity of the L7f probes was maintained with 
a significant size increase (by ~30nm) for both the let7f and let7 mixture samples (Fig. 4.10), 
while the size changes observed for the let7a and let7g samples were not significant.  
 
Figure 4.10. Graph showing let7f probes detecting for let7f, 7a and 7g miRNA, and also the let7 
cocktail.  
 
P < 0.05 
P < 0.05 
P > 0.05 
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The L7f probes with let7a exhibited a size increase of ~10nm, and this can be attributed to the 
single mismatch and non-specific interactions. With 2 bases difference, the let7g samples 
exhibited little size increase. Statistical analysis showed that the let7f and let7 mix results did not 
differ significantly (p-value ~ 0.5), while the let7a and let7g samples were distinctly different 
from the positive readout of the let7f targets (p-value < 0.05). 
4.4 Conclusion 
We have developed an AuNP nanoassembly-based system for detection of let7 miRNA. The 
formation and growth of defined nanoassemblies resulted in changes in the scattering signatures, 
and was detected as distinct size changes on the DLS readout platform. This is especially 
applicable for the study of more subtle nanoassembly processes, such as in the formation of 
dimers and higher order -mers from monomers. The detection process was simple and direct with 
the hybridization of the probes to the miRNA target followed by DLS testing being the main 




levels, resulting in a sensitive, selective system that can detect for miRNA in a rapid manner. 
4.5 References 
1.  Munker, R.; Calin, G., Clin Sci 2011, 121, 141. 
2.  Brueckner, B.; Stresemann, C.; Kuner, R.; Mund, C.; Musch, T.; Meister, M.; Sültmann, H.; 
 Lyko, F., Cancer Res 2007, 67, 1419. 
3.  Vasudevan, S.; Tong, Y.; Steitz, J. A., Science 2007, 318, 1931. 
4. Iorio, M. V.; Ferracin, M.; Liu, C.-G.; Veronese, A.; Spizzo, R.; Sabbioni, S.; Magri, E.; 
 Pedriali, M.; Fabbri, M.; Campiglio, M., Cancer Res 2005, 65, 7065. 
5. Si, M.; Zhu, S.; Wu, H.; Lu, Z.; Wu, F.; Mo, Y., Oncogene 2007, 26, 2799. 
6. Jansson, M. D.; Lund, A. H., Mol Oncol 2012, 6, 590. 
7. Várallyay, É.; Burgyán, J.; Havelda, Z., Nat Protoc 2008, 3, 190. 
8. Stenvang, J.; Silahtaroglu, A. N.; Lindow, M.; Elmen, J.; Kauppinen, S. In The utility of LNA 
 in microRNA-based cancer diagnostics and therapeutics, Seminars in cancer biology, 
 Elsevier: 2008; pp 89. 
9. Miska, E. A.; Alvarez-Saavedra, E.; Townsend, M.; Yoshii, A.; Sestan, N.; Rakic, P.; 
 Constantine-Paton, M.; Horvitz, H. R., Genome Biol 2004, 5, R68. 
 73 
 
10. Liu, C.-G.; Calin, G. A.; Volinia, S.; Croce, C. M., Nat Protoc 2008, 3, 563. 
11. Qavi, A. J.; Kindt, J. T.; Bailey, R. C., Anal Bioanal Chem 2010, 398, 2535. 
12.  Varkonyi-Gasic, E.; Hellens, R., Quantitative Stem-Loop RT-PCR for Detection of 
 MicroRNAs. In RNAi and Plant Gene Function Analysis, Kodama, H.; Komamine, A., Eds. 
 Humana Press:  2011; Vol. 744, pp 145. 
13. Wang, H.; Ach, R. A.; Curry, B., RNA 2007, 13, 151. 
14. Koshiol, J.; Wang, E.; Zhao, Y.; Marincola, F.; Landi, M. T., Cancer Epidem Bio 2010, 19, 
 907. 
15. Becker, N.; Lockwood, C. M., Clini Biochem 2013, 46, 861. 
16. Gao, Z.; Peng, Y., Biosens Bioelectron 2011, 26, 3768. 
17. Peng, Y.; Yi, G.; Gao, Z., Chem Commun 2010, 46, 9131. 
18. Deng, H.; Shen, W.; Ren, Y.; Gao, Z., Biosens Bioelectron 2014, 54, 650. 
19. Yang, H.; Hui, A.; Pampalakis, G.; Soleymani, L.; Liu, F. F.; Sargent, E. H.; Kelley, S. O., 
 Angew Chem Int Edit 2009, 48, 8461. 
20. Yin, H.; Zhou, Y.; Chen, C.; Zhu, L.; Ai, S., Analyst 2012, 137, 1389. 
21. Zhou, W.-J.; Chen, Y.; Corn, R. M., Anal Chem 2011, 83, 3897. 
22. Yang, S. W.; Vosch, T., Anal Chem 2011, 83, 6935. 
23. Yguerabide, J.; Yguerabide, Anal Biochem 1998, 262, 137. 
24. Jans, H.; Huo, Q., Chem Soc Rev 2012, 41, 2849. 
25. Huo, Q.; Litherland, S. A.; Sullivan, S.; Hallquist, H.; Decker, D. A.; Rivera-Ramirez, I., J 
 Transl Med 2012, 10, 44. 
26. Dai, Q.; Liu, X.; Coutts, J.; Austin, L.; Huo, Q., J Am Chem Soc 2008, 130, 8138. 
27. Pylaev, T.; Khanadeev, V.; Khlebtsov, B.; Dykman, L.; Bogatyrev, V.; Khlebtsov, N. G., 
 Nanotechnology 2011, 22, 285501. 
28. Miao, X. M.; Xiong, C.; Wang, W. W.; Ling, L. S.; Shuai, X. T., Chem-Eur J 2011, 17,  11230. 
29. Reynolds, R. A.; Mirkin, C. A.; Letsinger, R. L., J Am Chem Soc 2000, 122, 3795. 
30. Jeffrey, C., Chem Commun 2007, 3729-3731. 
31. Liu, Y.; Wu, Z.; Zhou, G.; He, Z.; Zhou, X.; Shen, A.; Hu, J., Chem. Commun. 2012, 48,  3164. 
32. Jans, H.; Liu, X.; Austin, L.; Maes, G.; Huo, Q., Anal Chem 2009, 81, 9425. 
33. Binder, H.; Preibisch, S.; Kirsten, T., Langmuir 2005, 21, 9287. 
34. Kim, T.; Lee, C.-H.; Joo, S.-W.; Lee, K., J Colloid Interf Sci 2008, 318, 238. 
35. Cao, Y. C.; Jin, R.; Thaxton, C. S.; Mirkin, C. A., Talanta 2005, 67, 449. 
36. Sampson, V. B.; Rong, N. H.; Han, J.; Yang, Q.; Aris, V.; Soteropoulos, P.; Petrelli, N. J.; 




CHAPTER 5: GOLD NANOSTRUCTURES FOR THE DETECTION OF PROTEIN 
BIOMARKER - DIMERIC GOLD NANOPARTICLE ASSEMBLY FOR THE 
DETECTION OF ESTROGEN RECEPTOR USING DYNAMIC LIGHT SCATTERING 
 
5.1 Introduction 
The value of biomarker detection was discussed in Section 2.1. In particular, ER is one 
biomarker in the characterization of breast cancer - a disease that afflicts a significant number of 
people worldwide. ER is a tumour marker which is highly implicated in breast cancer, for 
patients who are ER-positive show survival rates which are drastically different from those who 
are ER-negative. It has been shown that endocrine therapy, a main treatment means in breast 
cancer care, has substantial benefits in patients who are ER-positive and hence boost survival 
chances 
[1-4]
. Thus, the screening of the presence and level of ER is taken by medical personnel 
before deciding on the treatment course for patients. This is significant as potentially the most 
effective treatment is given to patients in a timely manner, while minimizing costs outlay and 
allaying the emotional stress of patients.  
The traditional way of detection – ligand binding assay using radioactive probes, have since 
given way to immunohistochemistry (IHC) methods, which is the technique practised in most 
labs and medical institutions 
[5]
. However, there are a number of problems associated with the 
IHC method. Delays in the fixation process typically result in proteins degradation, while 
differences in the tissue blocks used and fixation time will lead to variations in the 
immunostaining. Results reproducibility is thus compromised. The complex cellular environment 
contain other proteins which, though not specific to the antibody, might still affect the IHC 
process due to non-specific interactions 
[6, 7]
. Due to its inherent shortcoming, IHC is at best 





Hence, there is motivation to improve the detection of ER, specifically through the use of 
nanotechnology, and metallic nanoparticles (NPs). Metallic NPs, due in large part to their unique 
physical properties, have increasingly been utilized in bio-diagnostic systems 
[10-13]
. In particular, 
AuNPs are ideal as labels and readout mediators, owing to their unique surface plasmon 
resonance properties 
[14-17]
. Antibody-tagged AuNPs are used for immuno-assays 
[18, 19]
, and 
fluorophore-linked AuNPs are utilized in molecular beacons and detection systems based on 
FRET 
[20-22]
. AuNPs have also enabled the study of complex biomolecular processes such as the 
binding of transcription factors (TFs) to specific DNA sequence and their interactions, which are 
the focus of many scientific endeavours. TFs are involved in many disease pathogenesis 
pathways and thus have significant diagnostic and therapeutic potentials 
[23, 24]
. For example, a 
colorimetric method mediated by aggregated AuNPs was devised for the detection of the TATA 
protein, a key TF in the cellular replication machinery 
[25]
. Also, NF-κB p50 activity was 
detected via the red to blue AuNP colour change, which could easily be observed by naked eye 
[26]
. Furthermore, the binding of ER to its putative DNA recognition site was studied, presenting 
not just a successful detection strategy but also giving insights to the binding stoichiometry, 
which was perhaps even more valuable scientifically 
[27]
. AuNP-based assays have the 
advantages of being direct, rapid, label-free, and equally, if not more, sensitive compared with 
the traditional laborious electrophoretic mobility gel shift and enzyme-linked immuosorbent 
assays 
[28, 29]
. As mentioned in the earlier chapters, the drawback of colorimetric AuNP detection 
systems is that aggregation might be triggered by non-target analytes and changes in ionic 
concentrations
 
such as sodium ion levels, which result in significant background noise and non-
specific readouts. Typically, stringent control of the reaction and hybridization environments 
must be done to minimize such undesirable effects.  
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On the other hand, through measuring fluctuations in the scattered light intensity of biological 
samples in Brownian motion, DLS is used to determine the size and size distribution of samples 
studied. The sensitivity and reproducibility of the DLS makes it an ideal technique for the 
characterization of samples at micro- and nano-levels. The foremost diagnostic platform making 
use of AuNP and DLS is the NanoDLSay platform, which has been discussed in chapters 2 and 
4. The technique detects target analytes either via probe aggregation due to analyte binding or 
multiple analytes binding onto a single probe particle, both of which lead to an overall increase 
in size that is captured on DLS. Furthermore, the DLS platform allows a fast readout in as short 
as 5 minutes, thus ensuring that protein samples remain stable and not degrade during the 
experimental processing. Other DLS-based protein detection works include antibody-loaded 
AuNPs aggregating in the presence of alpha-fetoprotein, which was validated with serum 
samples in the biologically relevant ranges (0.1–0.4 mg/ml) [30]. DLS was also used to study how 
bovine serum albumin (BSA) structure is affected by pterodontic acid, thus demonstrating its use 
in the design and screening of potential protein therapeutics 
[31]
. However, as mentioned in the 
Introduction and the previous chapters, there are many shortcomings associated with a purely 
aggregation-driven platform, as many factors other than specific probe to target interaction might 
trigger the aggregation process which lead to in false positives. Also stringent controls have to be 
done to ensure that the environment is conducive for aggregation while not interfering with the 
detection process. Thus, while aggregation is good as a direct and clear readout, there is a need 
for careful control over the molecular interactions and endpoint readout. 
We have devised a nanostructure system utilizing a well-defined dimeric AuNP system which, 
when coupled with the DLS, can be used to detect the binding of TF on DNA. In our proposed 
method (Scheme 5.1), the native estrogen response element (ERE) consensus sequence for ER is 
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designed to be part of the dsDNA linker localized between the AuNPs, which allows ER binding. 
By using dimers which are formed from single ssDNA-bound conjugates joined by a linker 
sequence, we are able to have a defined position for ER binding. This gives control over the ER-
ERE, as well as ER-bound dimer interactions, and minimizes extensive and uncontrolled AuNP 
aggregations seen in many other systems. Upon ER binding, an increase in the overall size of the 
ER-DNA-AuNP complex can be detected via the DLS platform. The dimers present a distinct 
readout on the DLS and we postulated that positive ER-dimer interaction will present a signal 
readout that is distinct from the dimer-only signal.  
 
Scheme 5.1. Schematic depicting the design of the detection system. Two AuNPs are hybridized 
to a common linker, forming an AB dimer with the ER binding site (ERE) localized in between. 
When incubated together, the dimer and ER would interact through ER binding onto ERE, thus 
forming the dimer-ER complex.  
 
5.2. Experimental Section 
 5.2.1 Materials 
Hydrogen tetrachloroaurate (III) trihydrate, trisodium citrate dihydrate, tannic acid, 4,4’ 
(Phenylphosphinidene)bis (benzenesulfonic acid), dipotassium salt hydrate 97% (PPBS), NaCl, 
MgCl2, and trisborate-EDTA (TBE) buffer were purchased from Sigma–Aldrich. Tris buffer (pH 
8), agarose powder, and synthetic DNA molecules (with either 3’ or 5’ thiol modifications) were 
purchased from were purchased from Integrated DNA Technologies Pte Ltd. Oligo-etheylene 
   + → 
AB dimer system 
ER  







B A B A 
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glycol was purchased from Sigma-Aldrich Co. Milli-Q water with resistance >18MΩ/cm was 
used throughout the experiments. Estrogen receptor proteins were purchased from Invitrogen. 
 5.2.2 Synthesis and characterization of gold nanoparticles 
11nm AuNP synthesis using citrate and tannic acid was as described by Handley et al 
[32]
. AuNP 
products were characterized first with UV-vis spectroscopy (Varian Cary 50Bio), followed by 
transmission electron microscopy (TEM, JEOL JEM-2100F, 200 kV). The electron micrographs 
were analyzed with the Image J software (NIH) over an average of at least 200 particles.  
 5.2.3 Fabrication and recovery of dimers 
The AuNPs synthesized were first passivated with PPBS for at least 4 hours, followed by 
incubation with one of three 80 base single-strand DNA (ssDNA) - A, B, and C (Table 5.1), and 
then passivation with thiolated oligo-ethylene glycol (OEG) for 24 hours.  
 
Oligo A 5’ (SH) –TTT TTT TTT TGG ACA TCA AAA TGT GTT TTT TAC TGG GAC TTT TGT TCA 
TAA AAT AGT TTT CTG CAT AGC CTC TTT GATTA 
 
Oligo B 5’ GAT TAA CTG TCC AAA GTC AGG TCA CAG TGA CCT GAT CAA AGT TAA TGT AAC 
CTC AAC CTG GAC AAA GCT ACT AGT TTT TT– (SH)  3’ 
 
Oligo C 5’ GAT TAA CTG TCC AAA GTC AAT CGC CAG CAC GAT GAT CAA AGT TAA TGT AAC 
CTC AAC CTG GAC AAA GCT ACT AGT TTT TT –(SH)  3’ 
 
Linker AB 5’ TTACATTAACTTTGATCAGGTCACTGTGACCTGACTTTGGACAGTTAATCTAATCAA 
AGAGGCTATGCAGAAAACTATTTTATGAACAAAAGTCCCAGTA 
 
(the ER binding site - ERE, is shown underlined and in bold)  
 




Table 5.1. Sequence of A, B and C ssDNA. A and B is complementary to linker AB, while 




These AuNP-ssDNA conjugates were gradually raised from 200mM to 600mM NaCl 
environment with a 5M NaCl solution. The conjugates were subsequently washed in 50mM Tris 
and NaCl buffer. Conjugates were separated on a 3% agarose gel (5V/cm, 180min) and 
conjugate monomers bearing single ssDNA were recovered 
[33, 34]
. The concentrations of the 
probes were estimated using UV-vis spectrometry. Two different conjugate monomers were 
hybridized to their complementary target (probes A and B to target AB; probes A and C to target 
AC), with the target amount fixed at 1pmol and at a 1:1 probe to target ratio. After 1 hour 
incubation, the samples were separated in a 3% agarose gel at 75V for 45 minutes under room 
conditions to visualize the formation of defined dimeric assembly, which were subsequently 
recovered through the excision and dialysis of the dimer gels. The recovery of the desired 
dimeric nanostructures was confirmed by TEM as well as further gel runs. 
 5.2.4  Binding of the ER protein on gold nanoparticle dimers and DLS testing 
ER proteins (either ERα or ERβ) stored at -80°C were thawed and added immediately into a 
cuvette containing the AuNP dimers. The protein and AuNP dimers were mixed well through 
gentle pipetting. The cuvette was then placed into the holder in a DLS spectrometer (Nano ZS 
Zetasizer, Malvern), and the contents were allowed to incubate while the machine equilibrated 
and optimized the detection settings. Subsequently, a 10-second measurement was taken and an 
average of 15 measurements was done per sample. In total, approximately 5 minutes was 
required per sample. In order to present more distinct readouts, a longer incubation time of 30 






5.3 Results and Discussion 
 5.3.1 Experimental design and proposed detection mechanism 
In Fig. 5.1, the 11nm AuNP dimer system exhibited a singular distinct peak with an average size 
of approximately 30nm, which was slightly larger than the sum of the two individual AuNPs 
combined. This suggested that the dimers formed on and recovered from the gel remained were 
stable and amenable for ER detection. When the dimers were incubated with the ERβ protein, the 
DLS readout showed two clearly distinct peaks and population distributions. The previously 
singly-peaked AuNP population exhibited another peak in the 200nm region.  
 
 
Figure 5.1. DLS readout of the AB dimer system before and after ERβ addition. The dimer-only 
system exhibited a single peak, whilst the dimer-ER system showed two distinct peaks. The 





Figure 5.2. TEM images showing the dimer system before and after incubation with ERβ. 
Clusters of sizes greater than 100nm were observed after ERβ addition.  
 
From the TEM images (Figure 5.2), clustering of particles was clearly observed after ERβ 
addition. Taking into account that DLS measures the hydrodynamic size of particles in the 
system, there is a distinct correlation between the TEM and DLS readouts. Given the relatively 
small size of ERβ, it is not possible that a single binding event could elicit such significant size 
change. Thus, we postulate that this ‘complex peak’ was most likely due to the interactions 
between dimers mediated by the ER present. The proteins side chains of ER contain functional 
groups which could interact with one another, hence drawing close the dimers and leading to the 
observed clustering phenomenon. While basic residues and thiol moieties on proteins were 
known to interact non-specifically with AuNP surfaces 
[37]
, in this case, non-specific attachment 
of ER onto AuNP surfaces was minimized through the OEG used to passivate the AuNP surface 
at a 500:1 OEG to AuNP ratio. The technique we present is different from the one reported by 
Tan and co workers, in which all different TF states (dsDNA-only, TF-only and dsDNA-TF 
complex) showed distinct readouts when tested with AuNPs. That was achieved using 
unmodified AuNPs, and based on the different degrees of AuNP aggregation 
[27]
. But the 






cause AuNPs to cluster and aggregate 
[36]
. Thus, there is a need for better control of the AuNP-
TF interaction to bring forth a distinct readout change, which we hope to achieve using the 
dimeric ERE-bridged AuNPs. 
A distinct advantage of detecting such a phenomenon on the DLS platform is that the intensity of 
the DLS readout is dependent on the particle size of the system. As the particle size increases 
(such as from ER-binding and subsequent particle clustering), the intensity would be amplified. 
In other words, target binding would lead to an amplification of signal readout without 
modifying the system or significant post-processing, and this could enhance the system 
sensitivity. This is also a label-free detection method, and ER is detected in its native form, as 
desired in biomarker sensing in general. Potentially, this allows for a sensitive and rapid means 
to detect and study TF actions. A point of note is that the ER-ERE interaction could not be 
studied on their own on the DLS without the transduction of the signal readout by AuNPs (Fig. 
5.3A). Furthermore, the DLS signal of the AuNP could also suppress the light-scattering signal 
from unbound proteins and no other interfering signals attributable to the non-binding protein or 




Figure 5.3. (A) DLS readouts of ER-only and ER+ERE systems, in the absence of AuNPs; (B) 
DLS readouts of ER-only and ER incubated with unmodified AuNPs. 
 
 5.3.2 Control experiments to validate the system 
To demonstrate the feasibility of using DNA-linked dimeric AuNPs to generate unique DLS 
readout for sequence-specific ER detection, we have conducted DLS analysis of different AuNPs 
nanostructures and studied their interactions with ER (β subtype). We first tested the citrate-
anion capped AuNPs (starting material used to fabricate DNA-linked dimeric AuNPs) with the 
addition of 10 nM ERβ, which resulted in significant particles aggregation and shifting the entire 
population of AuNPs on the DLS readout from 30 nm (empty bar) to around 500 nm (solid bar) 





ERonly ER + ERE 
ER only 





Figure 5.4. DLS analysis of the ERβ interaction with different AuNPs conjugates (A) citrate-
anion capped AuNPs; (B) OEG passivated AuNP; (C) OEG passivated AuNPs bearing one 
strand of ssDNA; (D) dsDNA-linked AB dimeric AuNPs. The particle size distribution of 
different AuNPs systems before and after addition of 10 nM of ERβ are indicated by the ‘empty’ 
and ‘solid’ bar charts, respectively. 
 
This is due presumably to the electrostatic interactions of citrate-capped AuNPs and the ERβ that 
induced the irreversible, bulk aggregation of the AuNPs. Therefore, in preparation of the DNA-
linked dimeric AuNPs, citrate-capped AuNPs were passivated with thiolated OEG at a 500 fold 
OEG:AuNP ratio to negate the surface charges. As shown in Figure 5.4B, the OEG-capped 
AuNPs were highly stable in the presence of ERβ, with the DLS readouts being essentially 
identical before and after ERβ addition. Next, we synthesized citrate-capped AuNPs of 11 nm 
core diameter, passivated with OEG and functionalized with 80-mer single-strand DNA 
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(ssDNA). This was done first through stoichiometric control, followed by agarose gel 
purification, as the size of AuNP and length of ssDNA resulted in conjugates that presented 
discrete bands on the gel that could be recovered subsequently. Two types of conjugates, A and 
B, were prepared. When the purified OEG-passivated AuNPs containing one strand of ssDNA 
were incubated with ERβ, there was a slight right-shift of about 10 nm in the overall system size 
(Fig. 5.4C), which was attributed to interactions between the AuNPs. Possibly, the non-specific 
binding of ERβ to the monomeric ssDNA-AuNP conjugates through weak electrostatic 
interactions could have resulted in this limited size increment.  
On the other hand, when the A and B conjugates were mixed with a 100-mer linker AB (which 
contained a 50-mer complementary sequence to each A and B conjugates on the opposite ends), 
only AuNP dimers were formed but not other nanostructures. The resulting double-stranded 
DNA (dsDNA)-linked AuNP dimers contained the consensus wildtype ERE sequence 
(GGTCAnnnTGACC) to which ERβ could recognize and bind specifically. The DLS readout of 
AuNP dimer system exhibited a singular distinct peak with an average size of approximately 30 
nm (empty bar, Fig. 5.4D), slightly larger than the sum of the two individual (11 nm) AuNPs 
combined, which was expected as the AuNPs were bridged by a total of 160 base-pairs of 
dsDNA. Besides the singular distribution of dimer peaks, no other peaks were observed. 
Following the addition of ERβ to the as-fabricated dsDNA-linked AuNP conjugates (AB dimer), 
the DLS readout presented two distinct particle size populations, with the appearance of a 
‘complex peak’ in the 200-300 nm region (solid bar, Fig 5.4D), followed by a decrease in the 
DLS signal intensity of the original dimeric peak - a unique optical signature which is believed to 
be the result of the sequence-specific binding of ERβ onto the ERE-conjugated AuNPs dimers. 
TEM images showing the clustering of AuNPs was shown in Fig. 5.2. As already mentioned, 
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basic residues and thiol moieties on proteins are known to interact with AuNPs surfaces 
[37, 38]
, 
but in this case, non-specific attachment of ER onto AuNPs was minimized as shown previously 
via OEG passivation. As dimer interacted with ERβ, the overall size of the system was also 
increased, and the scattered light intensity would be many folds higher, in turn amplifying the 
signal.  
Moreover, the study could be done with minimal amount of AuNP probes as AuNPs samples that 
showed no appreciable signal on the UV-vis still presented a clear signal on DLS (Fig. 5.5), 
which showed the advantage of DLS over conventional spectroscopic techniques.  
 
Figure 5.5. DLS readout of different AuNPs at increasing dilutions/ decreasing UV absorbance. 
Even at negligible absorbance, the AuNPs still presented a distinct readout on DLS, thus 
showing the superior sensitivity of the technique. The size increase mechanism of the technique 
exploits this property for even more distinct readout as the intensity is dependent on the size of 
the system. 
 
(at 520nm wavelength) 
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The amount of probes could also be purposefully kept low such that even if ER is at low 
concentrations, their interaction with ERE could still lead to an appreciable positive readout. Last 
but not least, this is also a label-free detection method where ERβ is detected in its native form, 
as desired in biomarker sensing in general. Potentially, this allows for a sensitive and rapid 
means to detect and study TF binding interactions. 
 5.3.3 Sequence selectivity and protein specificity 
To highlight the sequence selectivity of the technique, a different type of dimers, AC, was 
fabricated from oligo A and C AuNPs conjugates carrying one ssDNA linked by a 100-mer AC 
linker (Table 5.1). Different from the wildtype AB dimeric AuNPs probes, the AC dimers 
contained a mutated DNA sequence where the core binding sequence of ERE was scrambled. 
When 10 nM ERβ was added to the AC dimers, a complex peak was observed, but at a much 
lower intensity as compared to their AB counterparts (Fig. 5.6A). This was attributed to the non-
specific and also electrostatic interactions between the AC dimers and ERβ.  
 
Figure 5.6. (A) AC dimers consisting of 11nm AuNPs joined by dsDNA containing mutated 
ERE sequence was fabricated and tested with 10nM ERβ. Complex peak were observed, but at a 
much lower intensity, thus showing the sequence-selectivity of the technique; (B) AB dimers 
were queried with a non-specific protein – BSA, and there was little change in readout both 




And since changes in the TFs levels in cells are the subject of much scientific curiosity, such as 
the reprogramming of stem cells and study of oncogenic pathways 
[39, 40]
, any system querying 
the cell extract has to be minimally affected by the presence of many different proteins and not 
give non-specific readouts. In this study, we have queried the same 11 nm AB dimers with BSA 
to establish the specificity of the system for the ER protein. At comparable concentrations of 
protein, we found that the size change of the system was minimal, and that no complex peaks 
was observed through time (Fig. 5.6B). This showed that the appearance of the complex peak 
was due to the presence of specifically-bound ERβ protein while non-DNA binding proteins such 
as BSA would interact minimally with the DNA-linked dimeric AuNPs system.  
 5.3.4 Time- and concentration- dependence of readout 
For the bioassay development, it is important to quantify the amount of analytes at low detection 
limit, as well as establish the rapidity of the technique. We had first analyzed the changes in the 
complex peak relative to original dimer peaks over time upon adding 10 nM ERβ to the AB 
dimers. As seen in Fig. 5.7, the detection took only 5 minutes with the appearance of the 
complex peak, which suggested that DLS could promptly pick up and visualize any interaction 
between ER and ERE, mediated by the AuNP dimers. Through time, the size of complex peak 
relative to the dimer peak increased. Such time-dependent kinetics was typical of binding 





Figure 5.7. Time-dependent study of the AB dimers interaction with 10 nM ERβ over 30 
minutes. The complex peak was observed at 5 minutes and the decrease in dimer peak intensity 
was accompanied by the growth of the complex peak. 
 
Furthermore, we demonstrated that the unique optical changes of the ‘complex’ peak versus the 
‘original’ dimer peak was ERβ concentration dependent. Fig. 5.8 showed the particle size 
distribution of AB dimers in the presence of different amount of ERβ, with larger size changes 
corresponding to a greater amount of ERβ added (at 30 minutes after ERβ addition). The results 
suggest the technique has the potential to quantify the amount of proteins. This could be 
achieved through measuring the average size of the whole system through evaluating the dimer 
and complex peaks together, and the average size of the system is listed in Table 5.2. It could be 
seen that the increase in the average size of the system was concentration-dependent. In addition, 
the standard deviation of the distributions got wider at higher concentrations, which was 
attributed to the growth of the complex peak. However, the clustering of AuNPs is a 
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Figure 5.8. The AB dimers were queried with different concentrations of ERβ (1, 2.5, 5 and 10 
nM) at 30 minutes after ER addition. The intensity of the complex peak relative to the dimer 
peak was incrementally higher as more ERβ was used.  
 
 AB dimers AB dimers + 
1nM ERβ 
AB dimers + 
2.5nM ERβ 
AB dimers + 
5nM ERβ 
AB dimers + 
10nM ERβ 
Average system 
size (nm)  
30.31 ± 3.98 55.6 ± 2.0 82.2 ± 10.8 101.4 ± 12.1 149.6 ± 61.9 
 
Table 5.2. Average size of AB dimer system, after addition of ERβ. 
 
Potentially, the sensitivity of the technique could be enhanced through further optimizations in 
the amount of probes used and the binding conditions. One distinct advantage of DLS over 
conventional spectroscopic technique as determined from our works was that the amount of 
probes required to elicit the readout was much lesser as we did not require a high threshold 
concentration of AuNP such as detections by naked eye or UV spectroscopy, while at no 
discount of the speed and ease of readout. 
 5.3.5 Detection of ERα, using 11nm dimers 
Having established the detection of ERβ, we next applied the dimer system to study ERα, an ER 
isoform known to bind with stronger affinity to ERE. When 2.5nM ERα was added to 11nm AB 




AB dimers + 
10nM ERβ 
AB dimers + 
5nM ERβ 
AB dimers + 
2.5nM ERβ 




TEM images which showed significant particle clustering of the originally dimer-predominant 
population (Fig. 5.9). 
 
Figure 5.9. DLS readouts of AB dimers incubated with 2.5nM ERα. 
 
This reinforced the notion that the dimers, with their ER binding sites, would exhibit a distinct 
signal change on the DLS with the observation of a complex peak, when dimer-ER interaction 
led the dimers to progressively cluster and aggregate. The detection of both isoforms of ER has 
further shown the versatility of the technique. Potentially, the system could be adapted for the 
detection for other TFs, while the size of AuNPs used could also be studied such that the size 
change of the system and intensity of the signal readout could be made more apparent, thus 







We have developed an ER protein detection platform which combines the use of dimeric AuNP 
nanostructures carrying the ER-specific binding site, and dynamic light scattering as the readout 
platform. We have studied the effect of binding sequences and target protein, and found that the 
technique was highly sequence and target specific, with the presence of ERE being required for 
ER binding. This simple and direct detection platform represents a new way of detecting and 
investigating gene-protein interactions in a label-free, sensitive and timely manner.    
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CHAPTER 6: MODULATION OF G-QUADRUPLEX-MEDIATED GOLD 
NANOASSEMBLY BY MOLECULAR HAIRPINS AND THE USE FOR MICRORNA 
DETECTION 
 
6.1 Introduction  
The works presented in the earlier chapters have been centered on the formation of 
nanostructures, and how these assemblies come about due to the presence of target biomarkers 
such as SNPs, miRNA and transcription factors. The focus is mainly on the successful detection 
of the biomarkers, with the AuNP-DNA-biomarker assemblies being a resultant readout. In this 
chapter, we instead focus on a unique property of DNA that was first mentioned in Section 2.3.1 
- the quadruplex formation due to G-repeats, and study how this sequence and property can be 
used in the nanoassembly process, and apply the nanoassembly process to the framework of 
biomarker detection.  
Amongst the many properties of nucleic acids in addition to the well-known Watson-Crick 
pairings, one of the most interesting is their ability to form unique secondary structures. In 
particular, when four guanine (G) bases are in a coplanar arrangement and held by Hoogsteen 
hydrogen bonds, a G-quartet is formed. G-quartets, when stacked together, result in the G-




. The structural and 
topological arrangement is of much scientific curiosity as the quadruplex can be formed in either 
intra- or inter-molecular format, giving rise to monomeric (single strand), dimeric (two strands) 
configurations, and more. In addition, there are many ways the adjacent nucleic acids can be 
arranged, such as in parallel, anti-parallel or hybrid conformations 
[5, 6]
. More importantly, it has 
been discovered that G-quadruplexes have significant physiological importance as they are found 
in telomeres, and in oncogenic promoter sites. The formation of the G-quadruplex is associated 
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with the inhibition of telomere extension and perform a regulatory role on errant cell division 
[7, 
8]
. This has prompted blossoming research on the quadruplex, such as the development of ligands 
that can stabilize these structures as anti-cancer drugs 
[9, 10]
. Thus, there is a need to develop 
techniques that allow the study of quadruplexes, and the efficient and accurate screening of 
quadruplex-stabilizing ligands, all of which puts the focus on the successful detection of the 
quadruplexes in the first place.  
There are a number of well-utilized techniques and platforms for the detection and study of 
quadruplex behaviour. Circular dichroism (CD) is the dominant method in quadruplex study, as 
quadruplexes exhibit signature CD readouts. The presence of a negative peak at approximately 
240nm together with a strongly positive one at 260nm on the CD spectrum indicates a Type I 
conformation wherein two G-quartets are stacked with hydrogen bonds in the same orientation; a 
Type 2 conformation involves the stacking of G-quartets with hydrogen bonds in the opposite 
direction, giving rise to negative band at 260nm and a positive band at 290nm 
[11]
. While CD 
provides characteristic quadruplex readouts, the variabilities hamper its use as a quantitative 
quadruplex detection platform. UV thermal melting spectra is another technique that provides 
information to the presence of quadruplexes due to the relative change in the absorbance at 
distinct wavelengths (295nm), but sequences without G repeats also show strong UV absorbance 
at 295nm 
[12]
. This creates ambiguity in the definitive detection of the presence of quadruplexes.  
The strategy of using nanoparticles (NPs) with unique properties as readout mediators has 
allowed molecular processes such as the quadruplex formation to be better represented in a more 
direct manner. AuNPs, owing to their signature optical readouts have been used in tandem with 
DNA sequences containing G-repeats or poly-Gs (PGs), and the quadruplex forming process is 
leveraged for biosensing. For example, G-rich oligonucleotide conjugated to AuNPs could 
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induce a distinct blue to red shift due to the aggregation of the AuNPs triggered by the formation 
of quadruplexes 
[13, 14]
. And this aggregation concept had been extended to the detection of ions 
such as Ag
+
, and ligands wherein the presence of the targets led to quadruplex formation and 
AuNP aggregation, presenting an immediate and direct positive readout 
[15, 16]
. In particular the 
quadruplex-stabilizing ability of the ligands is also indicative of their potential as anti-cancer 
drugs. In a different design, a FRET-based system using a fluorophore-quencher combination 
held together by a common quadruplex forming sequence was reported, which leveraged on the 
quadruplex formation process for sensitive nucleic acid sensing 
[17]
. Herein, instead of being the 
target, ligands such as beberine and ZnTCPP were used to induce quadruplex formation and 
detection of the specific DNA target. Also, G-quadruplex-based FRET systems were used as 
aptasensors, which further showed its versatility 
[18]
. In addition, horseradish peroxidase-like 
DNAzyme function of the hemin/G-quadruplex complex was utilized in tandem with AuNPs for 








. The screening of fluorogenic substrates for the hemin/G-quadruplex systems has 
enhanced its sensitivity, making the DNAzyme an even better sensing platform 
[21]
. And the 
platform had been further used for the detection of miRNA-21, lending a sensitive and label-free 
detection of an important cancer biomarker that is significantly upregulated in certain cancer 
subtypes 
[22]
. While the quadruplex property has been much utilized in detection processes, such 
novel DNA secondary structures are rarely used for structural studies such as in NP assemblies. 
Related works reported in literature using both AuNP and quadruplex are largely aggregation-
based, which inherently has shortcomings such as false positives. Thus, the quadruplex forming 
phenomenon can be better studied through more defined AuNP nanoassemblies, and this has 
wider implications in the realm of biomarkers detection. 
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We adapted the use of the PG onto AuNP, and studied the PG-AuNP system on different 
platforms – TEM, gel electrophoresis and DLS. We found that nanoassemblies were formed only 
when PGs were present, but not for other DNA sequences. Hence, we postulated that the PGs 
that were conjugated to AuNPs formed quadruplexes, which then mediated the nanoassembly 
process. In particular, the assemblies that formed exhibited a distinct readout on the DLS due to 
the large scattering cross section of AuNPs. This makes the AuNP-DLS tandem system a good 
surrogate readout in the detection of quadruplexes 
[23, 24]
. This quadruplex-mediated AuNP size 
change in the form of a signature distribution and size change is also previously unreported in 
literature. There was only a single report on the use of DLS in G-quartet studies, for the analysis 
of different structures adopted by native G-DNA 
[25]
. In addition, we studied the conjugation of 
molecular hairpins onto AuNPs together with the PGs and found that the hairpins exerted a 
modulating effect on the nanoassembly. We attributed this to the steric effect exerted by the 
hairpins, which prevented quadruplex formation, and thus could be utilized to control the 
nanoassembly process. This was evident when molecular beacons (MBs) were used in place of 
the hairpins, with a restoration of fluorescence coupling the system size increase. Both the 
fluorescence signal change and DLS readouts reinforced the notion that the hairpins modulated 
the quadruplex forming and nanoassembly processes. Various PG and MB loadings were 
studied, as well as in different K
+ 
concentrations. In addition, we have adapted the PG-AuNP-
MB system for the study of the let7a miRNA, a valuable biomarker in molecular and cancer 





6.2 Experimental Section 
 6.2.1 Materials 
Hydrogen tetrachloroaurate (III) trihydrate salt (made up to 10% solution), trisodium citrate 
dihydrate, tannic acid, 4,4’ (Phenylphosphinidene)bis (benzenesulfonic acid), dipotassium salt 
hydrate 97% (PPBS), NaCl, MgCl2, tris buffer (pH7), agarose powder and tris-borate-EDTA 
(TBE) buffer were purchased from Sigma–Aldrich. Potassium chloride was purchased from 
AppliChem. Synthetic DNA molecules (with 5’ thiol modifications), MBs (thiolated at 5’ end 
and with Cy3 at the 3’ end) and let7a microRNA were purchased from Integrated DNA 
Technologies Pte Ltd. Oligo-etheylene glycol was purchased from Sigma-Aldrich Co. Milli-Q 
water with resistance >18MΩ/cm was used throughout the experiments.  
 6.2.2 Synthesis of gold nanoparticles 
The synthesis of AuNP was based on the Handley protocol in which citrate and tannic acid were 
used for the reduction of colloidal gold 
[26]
. Through the control of the starting HAuCl4 and the 
amounts of various reductants (10% citrate and tannic acid), and the reaction time, AuNP 
products 11nm in diameter were obtained. The AuNP products were characterized first with UV-
vis spectroscopy (Varian Cary 50Bio), followed by transmission electron microscopy (TEM, 
JEOL JEM-2100F, 200 kV). The electron micrographs were analyzed with the Image J software 
(NIH) over an average of at least 200 particles. 
 6.2.3 Fabrication of gold nanoparticle conjugates 
The conjugation process was based on the protocol previously reported in our group 
[27, 28]
. The 
11nm AuNP were first stabilized with PPBS overnight. Following which, the PPBS-stabilized 
AuNPs were incubated with the relevant DNA to be conjugated (PG, TpG and/or MB), followed 
by OEG passivation. The DNA loading onto AuNPs was stoichiometrically controlled to ensure 
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that the loadings would be that desired (either 2x, 5x or 10x). The conjugates were then subjected 
to increasing Na
+ 
levels up 600mM Na
+
 to ensure that optimal conjugation was achieved, but 
without AuNP aggregation. The as-synthesized conjugates were then washed in 50mM Tris and 
NaCl buffer and made up to 25µl. The concentration of the conjugates was determined via UV 
spectroscopy and the absorbance-size relation as reported in literature 
[29]
. 
 6.2.4 Characterization of conjugates on TEM, gel electrophoresis and DLS 
On average, 1.5pmol of the conjugates was used for each experimental run. The appropriate 
amount of conjugates (typically 2µl) is dispersed in a buffer at the given experimental conditions 
(in tris, tris and NaCl, or K
+ 
buffer). The conjugates-in-buffer samples were dropped onto TEM 
copper grids and tested as such. More concentrated samples were required for the gel runs, and 
the conjugates were tested on 3% gel at 75V over 120 minutes, under room conditions. For DLS 
measurement, the samples were first diluted in buffer to 400µl in plastic cuvettes before testing. 
The DLS test protocol involved a 60-second equipment equilibration, followed by optimization 
and automated instrument testing (Nano ZS Zetasizer, Malvern). On average, each run consisted 
of 12 to 15 measurements, and the intensity readout was taken as indicative of the particle size 
distribution. For the annealing process, the as-fabricated conjugates were incubated at the 
required test conditions in well-plates at a total volume of 25µl, and the samples were heated to 
75°C followed by controlled cooling at 0.5°C decrease every 30 seconds. The annealed samples 
were then left on the tabletop for 120minutes before the DLS tests were carried out. 
 6.2.5. Fluorescence and size measurements of PG-AuNP-MB system 
The PG-AuNP-MB conjugates were first incubated with 5pmol let7a miRNA at the desired 
conditions of K
+
, followed by annealing and cooling at room conditions. The samples were then 
diluted to 200µl and placed in 96-well plates (Nunclon 96 Flat Bottom Black). The samples 
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fluorescence were measured from 600 to 800nm wavelength, at an excitation wavelength of 
598nm, and at a gain of 125 (Tecan i-control Infinite 200). After the fluorescence measurement, 
the samples were diluted from 200 to 400µl, and tested on the DLS for the system size change. 
6.3 Results and Discussions 
 6.3.1 Study of quadruplexes on different platforms (CD, TEM and gel   
  electrophoresis)  
In our study, we focused on two DNA sequences – TpG, which is derived from the human 
telomeric poly-G, whose multiple G unit repeats are known to form an intramolecular quartet 
and quadruplex structure; and PG, a multi thymine sequence terminated with five G (Fig. 6.1). 
Unlike TpG, PG does not have repeats of multiple Gs on the same strand and any quadruplex 
formed should be at the intermolecular level. These sequences have also been reported in 





Figure 6.1. CD spectra of (A) TpG (consisting of repeated poly-G sequences); (B) PG (poly-T 
with 5 terminal G residues). 
A. 













5’  (SH) – TTTTT GGG TTA GGG TTA GGG     
   TTA GGG A 
PG sequence:  
5’ (SH) – TTTTT TTTTT GGGGG 
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As shown in Fig. 6.1A, the CD spectra of TpG showed a number of distinct peaks that are typical 
of quadruplexes. In particular, the peak at around 275nm is typical of parallel conformations, 
while the negative peaks at 260 and 295nm reflect antiparallel orientations 
[30]
. The PG sequence 
(Fig. 6B), on the other hand, exhibited peaks at 275 and 290nm typical of parallel quadruplexes. 
The peaks at 265 and 290nm are also common to folded monomeric and dimeric structures 
[31, 32]
. 
While the CD data was in agreement with the literature results, it was apparent that there existed 
a great variability in the results. There are many different conformations that the quadruplexes 
can take, either in the singular or multi-stranded form, and the orientation of adjacent sequence 




 and other ligands also change the CD spectra 
[33]
. In 
addition, CD does not possess the ability to quantify the amount of PGs present. Thus, we 
extended the study of PGs and quadruplexes by associating them with AuNPs, in the hope that 
the complementary technique may offer to study biologically-relevant quadruplexes and to 
develop a different perspective in the analysis. 
We conjugated PGs to AuNPs and studied the AuNP conjugates (individual single AuNP with 
attached PG or TpG DNA) under TEM and with gel electrophoresis. In the TEM images shown 
in Fig. 6.2A, the PG-AuNP in buffer existed mostly entirely as single particle species and 
showed no inter-particle associations. When the same conjugates were dispersed in K
+ 
solution, 
however, it could be observed that significant portion of the population were found as well-




Figure 6.2. TEM images of (A) AuNP conjugated to TpG; (B) AuNP conjugated to PG. 
 





presence of the AuNP clusters/assemblies could be indicative of the quadruplex formation. The 
gel image in Fig. 6.3 was also in agreement with the TEM results, with multiple bands observed 
in addition to the bare AuNP band (control).  
 
Figure 6.3. Gel image of PG-AuNP conjugates, and controls (AuNPs-only, without any PG). 
 
Given that the short 15b DNA strands are known to be unable to resolve the AuNP conjugates 
into distinct bands, the different bands must be due to the AuNPs assembling with each other, 
first into dimers, which gave rise to the band below the bare AuNP band, and the higher order 
assembly bands thereafter. The results suggest that the presence of terminal Gs in the PG 
sequence and formation of quadruplexes brought together their associated AuNPs. A 
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representation of a four-conjugate AuNP assembly formation mediated by the formation of G-
quadruplex is shown in Scheme 6.1.  
 





While the figure is idealized as all the sequences would have to be perfectly aligned to bring 
together four AuNPs in a single assembly, and there are other factors such as PG loadings and 
AuNP size to consider, it shows a possible arrangement of AuNPs mediated by quadruplexes. 
This scheme is further reinforced by the TEM images shown in Fig. 6.2 in which there are no 
more than 4 AuNPs in an assembly. Potentially, the PG-AuNP conjugates can offer an 
alternative and complementary method to the study of quadruplexes in addition to established 
molecular techniques. 
 6.3.2  Unique readout of PG-AuNPs on DLS 
We characterized the as-fabricated PG-AuNPs (dispersed in 50mM Tris and Na
+
) on the DLS 
(Figure 6.4(i)), and a distinct single peak centered at ~100nm was observed. The size distribution 
centered at 100nm suggested that the PG-AuNPs existed not as single conjugate but as an 
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assortment of different nanoassemblies, which was in agreement with the TEM and gel results. A 
conjugate of similar AuNP size loaded with non-PG DNA of comparable length showed a single 
peak at around 30nm. Without PGs forming quadruplex, the conjugates existed as individual 
AuNPs without associating into higher order -mers. This reinforced the notion that quadruplex 
formation had led to the AuNP nanoassembly.   
To further investigate the DLS readout and its association to quadruplex formation, we annealed 
the PG-AuNP conjugates in excess free PGs, at conjugate to excess PG ratios of 1:1, 1:5 and 
1:10. As the conjugation process involved the use of high Na
+ 
conditions up to 600mM, it was 
likely that there would be quadruplex formed during the conjugation process. The annealing 
process would disrupt any preformed quadruplex structures, and the resulting individual 






Figure 6.4. Unique PG-AuNP readout with a peak centered around 100nm. From curves (i) to 
(iv), as additional free PG was added, the peak resolved into two after annealing, with a smaller 
peak at ~30nm which corresponded to the single conjugate species. The associated schematic 
illustrated the competition between the free PGs and the PG-AuNP conjugates, for quadruplex 
formation and nanoassembly. 
 
The DLS readouts in Fig. 6.4(curves (i) to (iv)) showed that the peak originally at 100nm 
resolved into two in the presence of excess PG – one at 100nm, and another at around 30nm. For 
the 1:1 ratio, the previously single peak at 100nm was observed together with another shoulder 
peak at 30nm, a size which corresponded to that of unassembled single conjugates. The shoulder 
peak at 30nm was more even more pronounced for the 1:5 ratio than that of 1:1 ratio. This 
suggested a reduction in assembly formation with more PG-AuNP conjugates remaining 
unbound. At a 1:10 conjugate to excess PG ratio, the two peaks were not as well-resolved. The 
absence of the peak at 100nm and a singular peak at around 50nm were observed, indicating 
more drastic shifts of the particle distribution and further reduction of the nanoassembly. These 
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observations could be attributed to the larger amount of free PGs providing greater competition 
for the PG-AuNP conjugates. The electrostatic repulsion between the AuNPs further contributed 
to the reduction in inter-conjugate interactions and assemblies. All these led to the reduced 
quadruplex formation within the PG-AuNP conjugate population in the presence of free PGs, 
resulting in less extensive nanoassemblies.  
It is worth to note is that the AuNPs did not form large aggregates since the loading of PG per 
AuNP was relatively low (5 PG per AuNP). In comparison, aggregation techniques centered 
upon quadruplex formation reported in literature used much higher loading of DNA on the 
AuNPs (60 to 100 times ratio) 
[14, 15]
. Given that multiple PGs had to interact favorably in order 
to form quadruplexes in the presence of stabilizing ligands and cations, a lower PG loading could 
facilitate a more controllable assembly process and result in more clearly defined structures 
rather than aggregates in an uncontrolled manner. This notion of controlled assembly (relative to 
uncontrolled aggregation) is one of the main themes in the various works presented in this thesis. 
The DLS results for AuNP conjugated with TpG at different additions of PGs (Fig. 6.5) showed 





Figure 6.5. AuNP-TpG at different ratios of PG. The system size corresponded to the AuNP-
TpG conjugate monomeric species. 
 
The TpG-AuNP conjugates at different conditions peaked at around 30nm with a narrow size 
distribution, which was reflective of single AuNP conjugate populations and negligible 
assembling of conjugates. This is attributed to the TpG sequence preferentially forming 
intramolecular G-quadruplexes due to the presence of multiple stretches of G repeats on the same 
DNA strand, thus the readouts indicative of nanoassembly processes were not observed. Fig. 6.6 
showed the readouts obtained for AuNPs passivated with OEG and without any conjugated DNA 
sequence. The peaks were nearly all identical in their positions with and without additional PG. 
Thus, the changes in the DLS readout and AuNP assembly was attributed to the presence of PG 
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Figure 6.6. AuNP passivated with OEG at different ratios of free PG. The AuNP (OEG) peaks 
remained the same with or without additional PG.  
 
 6.3.3. PG-AuNP nanoassemblies modulated by molecular hairpin  
To further study the nanoassembly process that we believe is brought about by the interactions 
between the PG sequences and their formation into quadruplexes in the presence of K
+
, we 
designed another system in which PG and molecular hairpins were both conjugated onto the 
same AuNP. As shown in Fig. 6.7, the 34-base long hairpin has complementary ends which 
hybridized into a 6-base pair stem and 22-base loop. With the presence of a loop structure, the 
hairpin exhibited a larger molecular footprint on the AuNP and the resulting steric hindrance 
could inhibit the neighbouring PGs from interacting with each other to form quadruplexes 
[34, 35]
. 
By having the hairpins onto the same AuNP as the PGs, the formation of the quadruplex could be 
modulated, which also gave control over the nanoassembly process. Also shown in Fig. 6.7, two 
types of PG-AuNP conjugates, one with 2 PG per AuNP and the other 5 PG per AuNP, were 
fabricated. The loading of hairpins was varied with 1, 2 and 5 hairpins on AuNP conjugates with 
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Figure 6.7. Effect of molecular hairpins on quadruplex formation and AuNP nanoassembly. Two 
loadings of PG (2 and 5 per AuNP amount used) were studied at different ratios of hairpin (0, 1, 
2, 5 or 10 hairpins per AuNP). Hybridized hairpin in the open conformation (far right) was also 
studied. 
 
For the various conjugate types, the system size was highly affected by the loading of the 
hairpins. For the 2PG per AuNP conjugates, the size of the system was around 50nm with no 
hairpin present, just over 40nm with one hairpin, and 20nm with 2 and 5 hairpins. It was 
apparent that, with a larger loading of hairpins onto the AuNP, the size of the nanoassembly 
system decreased and became similar to that of single conjugates. The presence of the hairpins 
inhibited the size increase, likely because the hairpins prevented PGs from interacting and 
forming quadruplexes, which in turn led to no assembly of the nanostructures. Similar outcomes 
were observed for the 5 PG per AuNP conjugates, in which the presence of at least 2 hairpins (in 
addition to 5 and 10) resulted in a system with an average size of around 40nm, while the 
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absence of hairpins caused the system to double in size. Despite a higher loading of PGs, 
molecular hairpins still exerted an inhibitory effect on quadruplex formation due to steric 
influence, and no discernible size increase was observed. Another important observation was that 
when the same 5PG-AuNP was loaded with 5 times hairpins in open conformation (via the pre-
hybridization with a complementary 22b sequence), the size increase was observed. It seemed 
that the double stranded sequences exerted a significantly lesser inhibitory effect on the 
nanoassembly, which might be due to their more rigid sequence and smaller molecular footprint 
as compared to the hairpins. Hairpins in an open conformation exhibited lesser inhibitory effect 
on the quadruplex formation, resulting in more ready nanoassemblies. 
 6.3.4. Developing the PG-AuNP-MB system 
Here, the molecular hairpins were replaced with molecular beacons (MBs) which had the same 
sequence as the hairpins, but with a Cy3 fluorophore attached at the 3' end. In the hairpin state, 
the Cy3 molecule is located at the base of the stem. When the MB is successfully conjugated 
onto the AuNP, the MB is brought into close proximity to the AuNP surface, resulting in the MB 
quenching via the nanoparticle surface energy transfer process, which is essentially a transfer of 
energy from the fluorescent MB donor to AuNP acceptor. This provided the basis to study the 
opening of the hairpin when a complementary 22b nucleic acid target was used to hybridize to 
the loop section of the hairpin. For proof-of-concept purposes, the loop was designed to be 





Figure 6.8. Relative fluorescence change of the PG-AuNP-MB systems after incubation with 
5pmol let7a. Three PG to MB ratios relative to AuNPs were studied (5:2. 5:5, 5:10), and each 
was tested at K
+ 
concentrations of 100, 300 and 500mM. The red dotted line represents the 
baseline (fluorescence change in the absence of target). 
 
After the PG-AuNP-MB was incubated with 5pmol let7a miRNA for 2 hours, the samples 
fluorescence was measured and compared to the PG-AuNP-MB without miRNA (conjugate-only 
controls). As shown in Fig. 6.8 above, for the 5PG-2MB system, there was an obvious 
restoration of fluorescence after the PG-AuNP-MB conjugates were incubated with 5pmol let7a. 
At 100mM K
+
, the relative fluorescence change was more than twice that of the conjugate-only 





levels were tested as one of the aims was to observe how the quadruplex 
formation and nanoassembly processes would be affected by the opening of the MBs. Since K
+
 
concentration have a significant bearing on quadruplex formation, it is one of the key parameters 
of study. For the 5PG-5MB system, the greatest relative fluorescence increase was 
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approximately 1.7 times for 100mM K
+
, 1.15 times for 300mM K
+
, and 1.02 times at 500mM 
K
+
. These restoration of fluorescence showed the definitive opening of the MBs when a 
complementary sequence (let7a) was incubated with the conjugates. When a high loading of MB 
(10x) was used, a 1.5 time fluorescence increase was observed at 100mM K
+ 
but no increment 
was observed at other K
+ 
levels. This was attributed to the high loading of MBs contributing to 
significant background noise, which caused the fluorescence change to be less obvious. 
 
Figure 6.9. Average system size of the PG-AuNP-MB systems, at various PG:MB ratios (5:2, 
5:5, 5:10, amounts relative to AuNP), studied across 100, 300 and 500mM K
+
. An AuNP-MB 
only system (without PG) was also studied. 
 
After incubation with miRNA and fluorescence measurement, the same samples were then tested 
on DLS. From Fig. 6.9, for all three systems, there were minimal size change at 100mM K
+ 
and 
the sizes were similar to that of conjugates not incubated with miRNA. This K
+ 
level might be 
unable to adequately induce quadruplex formation, especially with the interference of nearby 
MBs. The size increase was significant at both 300mM and 500mM K
+ 
with the system size 
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doubling or more. This was more obvious for both the 5PG-2MB and 5PG-5MB systems 
(~80nm) than the 5PG-10MB system (~30nm). The presence of MB in the open conformation 
still exerted a steric effect on the PGs such that quadruplexes could not readily form; Only at a 
high-enough K
+ 
concentrations was quadruplex formation successfully induced, resulting in 
nanoassemblies. The lesser size increase for the 5PG-10MB was attributed to the high loading of 
MB, which exhibited more steric hindrance and greater inhibition of quadruplex formation when 
incubated at the same amount of let7a as the other conjugate systems. These results further 
reinforced the idea that the size increase from the nanoassemblies was due to quadruplex 
formation and that the MB/hairpin DNA co-localized onto the same AuNP exerted a modulating 
effect. In the absence of PG, conjugates containing MB only exhibited no discernible size 
increase even after incubation with let7a. Cross hybridization between MBs did not contribute to 
the nanoassembly and size change. 
 6.3.5. PG-AuNP-MB for miRNA detection 
The PG-AuNP-MB conjugates were annealed with different amounts of let7a (25pmol, 5pmol, 
0.5pmol, 50fmol and 5fmol), and the fluorescence and average system size were measured. The 
detection was done in 300mM K
+
 as an initial test, as it had been shown previously to be a 
suitable condition for quadruplex formation, while at no risk of inducing AuNP aggregation. 
AuNPs conjugated to 5PG and 5MB were used as a model of study as it showed good 




Figure 6.10.  Dual tier detection of let7a miRNA using a PG-AuNP-MB system (5PG:5MB, at 
300mM K
+
). Blue - fluorescence intensity; brown - size of system. 
 
As shown in Fig. 6.10, the readout showed an increasing trend for both fluorescence restoration 
and system size change with respect to the amount of miRNA present. The results were also 
distinctly different from that of the control with an average increase of 5nm in size and 7% in 
fluorescence intensity at 5fmol let7a. Even at higher levels of miRNA, the system showed a 
positive trend with the fluorescence and size change being in agreement to let7a amount. 
The dual-tier actions of MB fluorescence restoration and quadruplex-mediated nanoassembly 
makes the PG-AuNP-MB system possible for nucleic acid detection, with let7a already shown as 
an example. The MB loop sequence could be designed to be complementary to the target DNA 
or RNA, and the presence of the target would lead to both the increase in the fluorescence and 
system size change under optimal K
+ 
conditions. Potentially, the dual readouts offered these two 
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characterized than conventional single readout systems, as the readouts reinforce each other to 
provide an added level of confirmation. 
6.4. Conclusion 
We have combined the G-quadruplex forming abilities of the PG sequence and AuNPs to 
achieve a unique nanoassembly system through quadruplex formation. This process was further 
modulated through the use of molecular hairpin, which exerted a steric effect and allowed the 
quadruplex to form only under specific conditions, giving control over the nanoassembly 
process. This control could be further enhance through varying loading of both PG and 
molecular hairpins and experimental conditions such as K
+
 level. The effect exerted by the 
hairpins was also demonstrated through molecular beacons. The successful fabrication of the 
PG-AuNP-MB led to the development of a let7a detection system and has greater potential for 
the sensing of more wide-ranging nucleic acids and cancer drug targets. This PG-AuNP-MB 
system is developed in accordance with one of the themes of the works presented in this thesis: a 
disease state could potentially be better characterized when queried across more factors, such as 
the DNA, RNA and protein levels. With the multi-factorial approach, the analysis of the disease 
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CHAPTER 7: CONCLUSION, FUTURE OUTLOOK AND RECOMMENDATIONS 
 
7.1 Conclusion 
The focus of this thesis was mainly on the development of a nanoassembly technique which, 
through the use of AuNPs and leveraging on their ideal physical properties, allowed the detection 
of a variety of biomarkers. There are many biomarkers that impacts the physiology, with genetic 
biomarkers holding the code that is interpreted at the transcriptome level (controlled by miRNA), 
and eventually translating into functional proteins that determine the well-being of an individual. 
All these reinforced the need to study, understand, and also detect biomarkers. 
The formation of dimeric AuNP structures was first shown for the detection of the G6PD gene. 
The successful formation of the dimers was visualized using the agarose gel platform, which 
complemented the coloured AuNP probes. And the difference in electrophoretic mobilities of 
different types of dimers was used to distinguish between the many variants in the G6PD 
mutants. The formation and growth of controlled AuNP assemblies was the main principle for 
the next level of detection, for miRNA of the let7 family. Unlike the agarose gel method, DLS 
was the platform of choice in this technique as the growth of the AuNP assemblies was ideally 
complemented with the DLS readout due to the large scattering cross section of AuNPs. Probes 
specific for different members of let7 family, and the presence of the perfectly-matched target 
resulted in the growth of the assembly and yielded stronger detection signals, leading to clear and 
distinct readouts. While the results are encouraging, both techniques still need further 
improvements in sensitivity in order to compete with the current cutting edge. A more sensitive 
system will bode well for detection processes, but care needs to be taken to ensure that the good 
rapidity and selectivity of the system are maintained while giving distinct readouts. 
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Dimeric nanoassemblies were then used as probes in the detection of the ER protein biomarker. 
This was made possible with the incorporation of the ER binding site into the DNA sequence 
bridging the two AuNPs in the dimer. Specifically, the ER binding site allowed the interaction of 
the protein with the dimers. This was visualized as a distinct peak signal on the DLS, thus 
affirming the presence of ER. The observation of the complex peak was in contrast to peak 
signatures in the absence of ER. This detection system has larger implications in that it has 
potential to be extended to the detection of other transcription factors, through the design of 
probes unique to the protein target of study. 
Last but not least, the use of novel DNA structures was explored, with the G-quadruplex forming 
DNA studied. The PG sequence was used together with AuNPs to achieve the G-quadruplex-led 
assembly of AuNPs. This was possible due to the unique association between the guanine DNA 
residues, enhanced by stabilizing ligands such as K
+
. The assembly process could be further 
controlled with the co-localization of hairpin DNA together with PG onto the same AuNP, which 
further evolved the novel use of DNA in nanoassembly processes. This eventually led to the 
development of a PG-AuNP-MB system for the detection of the let7a miRNA via a dual tier 
manner in which the binding of the target triggered both a restoration of fluorescence and 
increase in system size, which were mutually reinforcing. This was also significant in that it 
showed the possibility of a multifactorial readout, which could be further extended in a multi-
biomarker detection system. 
7.2 Future Outlook and Recommendations 
There are a few areas where the techniques presented in this thesis can be further developed, 
both in terms of improving the different techniques presented, as well as seeking progression to 
further develop alternative and novel designs and systems.  
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The first consideration is an area that the existing systems can immediately extend to, which is in 
the testing of actual real samples. As seen from Chapter 3, when the detection system moved 
from synthetic to clinical samples, there is additional difficulty in bringing forth as good and 
distinct a readout. In particular the dimer bands were fainter than expected, which could potential 
cloud any conclusions made. Analogously, there is motivation to test actual cell miRNA and 
protein extracts and validate the systems which I had developed. In the presence of complex 
environments such as serum or cell extracts, the presence of other proteins and cellular materials 
could interfere with the actual detection process, which pose an added challenge. However, while 
there might be difficulty in bringing forth as clear a readout, successful detection will also bring 
added credence to the techniques, which greatly enhance their application potentials. Thus, the 
as-developed systems should be applied to real samples and results should be exciting. 
Another potential development involves the miniaturization of the system and incorporate this 
into the overall detection process. The microfluidics platform presents much advantages for both 
probe fabrication and also the probe-target hybridization processes. With the enhanced mixing 
and concentration in a microchannel, there is potential to reduce the 2-day probe fabrication 
process which is currently been pursued. Furthermore, typical DNA detection techniques is 
dependent on passive hybridization, in which target molecules diffuse to the capture probes, such 
as in microarrays. This takes a long period of hours since target DNAs have a typically low 




/s (based on 18b oligonucleotides) 
[1]
. However upon 
transition onto a chip platform, it has been found that the hybridization efficiency is much 
higher, which has been attributed to enhanced mass transport 
[2]
. In addition to the sensitivity and 
rapidity of the microchannel detection method which makes it amenable for point-of-care use, a 
multichannel approach also lends it multiplexing capabilities, which analyze different targets at 
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high throughput. The combination of probe fabrication and hybridization will allow an integrated 
diagnostics system to be developed. One of the challenges, however, is to reconcile the 
difference in the length scale of the AuNPs (nm range) with that of the channel dimension (~µm 
range), which demand that the readout be presented in a distinct and apparent manner. This 
means that the assembly process upon successful detection has to lead to changes that can be 
readily visualized, or that they could be harnessed subsequently for testing on a secondary 
platform, such as DLS or the microplate reader. All these place a challenge on the system design 
and also the overall integration of the diagnostic system. 
The other area that the works could be extended is through the use of quantum dots (QDs). QDs 
exhibit many properties that make them ideal in biosensing applications. Due to the size (on the 
order of Bohr exciton radius), shape and composition of the QDs, the resulting quantum 
confinement effect yields optical properties such as a large absorption profile with narrow 
emission (with a full width-half maximum of less than 40nm) 
[3]
. In contrast, organic 
fluorophores show broad fluorescence emission spectra of more than 55nm. The QD emission 
can further be tuned through varying the size of QDs 
[4]
. The distinct emission signature of each 
QD size allows a mixture of different QDs to give clear and distinctive readouts without cross-
talks, which suggests good multiplexing potential 
[5]
. Adding to these properties are other 
favorable optical characteristics such high quantum yield and molar extinction coefficient, as 
well as resistance to photobleaching. All these desirable properties position QDs as superior tags 
and labels over conventional organic fluorophores 
[6, 7]
. In addition, QDs can be functionalized 
through ligand exchange reactions, which impart biofunctionality and recognition moieties such 
as antibodies, and allow them to be used as probes for detection and imaging purposes. Finally, 





. The difference is that QDs are typically used as donors, and given their superior 
optical properties, result in more efficient energy transfers and more drastic (clearer) signal 
changes.  
Similar to AuNPs, QDs are ideal as readout agent for the detection of nucleic acids. A QD 
biobarcode system was reported by Giri and co-workers in which a one-pot system of multiple 
QDs each showing distinct emission and labelled with a probe for nine genetic biomarker of one 
of five infectious agents (HIV, malaria, Hepatitis B and C, and syphilis) was developed 
[9]
. QDs 
have also been used in place of organic fluorophores in fluorescence in situ hybridization (FISH) 
techniques for the study and detection of mRNA, showing increased sensitivity, and allowing the 
ready screening of multiple targets 
[10, 11]
. A panel of protein biomarkers associated with prostate 
cancer was successfully screened using different QD probes, with the identification of single 
malignant cell in complex tissue environment. This addresses important issues in cancer 
screening such as tissue heterogeneity, and also allows the cancer condition to be better 
characterized 
[12]
. FRET-based systems have been developed for the detection of protein 
biomarkers, such as collagenase, a matrix metalloproteinases involved in breast tumour 
progression 
[13]
, and caspase 3, which is also a breast cancer biomarker 
[14]
. 
The potential of QD for biomarker detection suggests that their use could be further explore in 
addition to the AuNP-based techniques that had been developed, either as an alternative, or a 
complementary system. It is possible that AuNPs and QDs can be used in tandem to achieve 
novel assemblies or signal readouts. We have already done studies on the fabrication of QDs 
based on an ethylene diamine (EDA)-mediated ligand exchange method that is developed in our 
research group 
[15]
, and have successfully conjugated QDs with DNA probes. These conjugates 
were found to retain their optical properties while remaining soluble and stable in the aqueous 
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phase. They were then applied for the detection of miRNA, which presented positive readout 
changes. This is a work in progress, and further experiments would be done to complete the 
study.  
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